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This thesis describes an investigation into the dearomatisation reactions of phenols and naphthols 
catalysed by in situ generated hypervalent iodine(III) species, thereby producing a range of spiro-
oxazoline based compounds in achiral and enantio-enriched forms. 
The first part of this dissertation illustrates the synthesis of spiro-oxazolines via oxidative 
dearomatisation of phenol and naphthol amides mediated by 4-iodotoluene as catalyst and mCPBA 
as terminal oxidant. Different iodoarenes, catalysts, and solvents were scanned, however, 4-
iodotoluene and mCPBA provided the best results in hexafluoroisopropanol (HFIP). It was 
observed that altering the oxidant, iodoarene and solvent led to diminished yields in most cases. 
The stoichiometric and catalytic versions of the cyclisation were also successfully developed. 
 
The second part of this thesis details the synthesis of novel chiral iodoarenes bearing chiral 
appendages. A range of novel iodoarenes possessing chiral ureas, lactates, amides and carbamates 
were synthesised in good to excellent yields. The newly synthesised chiral iodoarenes were then 
employed and studied in the intramolecular oxidative dearomatisation reactions of naphthol 
amides to obtain racemic and chiral oxazoline based spirocycles. A significant increase in the 
enantioselectivities was observed when alcoholic solvents were used as additives in 
dichloromethane or chloroform at –20 ℃. In the presence of excess alcoholic solvent like ethanol, 
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(aq.)  Aqueous solution  
Brine  Saturated sodium chloride solution 
CTAB  Cetyltrimethylammonium bromide 
DCM  Dichloromethane 
DPPA  Diphenylphosphoryl azide 
EtOAc  Ethyl acetate 
Hex  Hexane 
HFIP  1,1,1,3,3,3-Hexafluoro-2-propanol 
IR  Infrared 
Me  Methyl- 
MeCN  Acetonitrile 
Mes  Mesitylene group 
MeOH  Methanol 
m-CPBA 3-Chloroperbenzoic acid 
MP  Melting point 
ND  No developement 
NMR  Nuclear magnetic resonance 
OAc  Acetate 
OTf  Trifluoromethanesulfonate 
PIDA  (Diacetoxyiodo)benzene 
PIFA  [Bis(trifluoroacetoxy)iodo]benzene 
 
x 
PTSA  p-Toluenesulfonic acid monohydrate 
RT  Room temperature 
Sat.  Saturated 
TFE  2,2,2-Trifluoroethanol 
THF  Tetrahydrofuran 
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Chapter 1 Introduction 
1.1. Iodine 
Iodine belongs to the halogen family (group 17). It is represented by symbol I and has atomic 
number 53. Iodine is a bluish black solid with lustrous properties. Iodine is a non-metal, least 
electronegative and highly polarizable, non-radioactive halogen.1 Compounds of iodine exist in 
various oxidation states. It can be found in -1, 0, +1, +3, +5, +7 oxidation states in organic and 
inorganic compounds. The reactivities of the hypervalent iodine compounds are somewhat similar 
to the properties of heavy metal reagents but without the toxicity issue. Iodine is also found in the 
human body as it is required for the normal functioning of the thyroid glands and production of 
thyroxin 1.1  
 
Figure 1.1: Structure of thyroxin 1.  
Due to the environmentally benign nature and inexpensiveness of iodine compounds, they have 
found huge applications in research and industry. In the past ten years, bulk prices of iodine were 
within the range of $20-100 per kilogram. Annually about 30,000 tons of iodine are produced from 
the estimated World’s total reservoirs of 15 million metric tonnes found mostly in Japan and 
Chile.2 
Industrial catalysis consumes about 16% of the world’s production of iodine. Synthesis of acetic 
acid by Monsanto and Cativa processes involves hydroiodic acid as a co-catalyst. Iodine is used 






In 1969, J. I. Musher used the term ‘hypervalent’ for the ions or molecules of elements of group 
15-18 having more than 8 electrons in their outermost shell.4 The first hypervalent iodine 
compound iodobenzene dichloride (PhICl2) was synthesised by a German chemist named C. 
Willgerodt in 1886 though it was known for its oxidising properties since 1893.5, 6 General features 
of hypervalent compounds were summarised by K. Akiba7 in the book “Hypervalent 
Compounds”. The formation of a hypervalent bond and possession of more than eight electrons in 
the valence shell by main group elements can be categorised into two classes: 
• Involvement of d-orbitals responsible for dsp3 or d2sp3 hybridisation. 
• Generation of a new highly polarised three-centre four-electron (3c-4e⁻) bond. 
The organic derivatives of polyvalent iodine commonly known as hypervalent iodine compounds 
have gained significant research activity in the past three decades. Due to their versatile and 
environmentally benign nature, they are widely used in organic synthesis as reagents.8, 9  
Compounds of iodine have the ability to form stable polycoordinate, multivalent compounds called 
hypervalent compounds when complexed with monodentate electronegative ligands like chloride. 
Factors responsible for widespread use of organoiodines in organic synthesis include, mild reaction 
conditions, low toxicity, easy handling and commercial availability of precursors as the key 
features of hypervalent iodine compounds. 
Iodine exists in +3, +5, +7 oxidation states in its hypervalent compounds. Structures 1.1-1.7 
represent the most common types of polyvalent iodine species. While the structures 1.2-1.7 are 
classified by using the Martin-Arduengo N-X-L nomenclature rules for hypervalent molecules. N 
shows the number of valence electrons, X being the central atom while L represents the number of 
ligands attached.10, 11  
 




In the earlier literature, compounds of iodine(III) were called iodinanes whilst derivatives of 
iodine(V) were known as periodinanes. However in the modern literature, lambda nomenclature 
is used whilst dealing with variable valence in organic compounds. The symbol λn represents a 
heteroatom in its nonstandard valence state (n) in a chemically neutral compound. The lambda 
convention is particularly more useful for naming iodonium salts like Ph2ICl as it reflects the true 
structure of the compounds having tricoordinated iodine atom.12  
Hypervalent bonding in organoiodine compounds can be best explained by molecular orbital 
description which involves a 4e⁻  ̶ 3c bond. In 1951, G. C. Pimentel and R. E. Rundle proposed the 
idea of three-centre four-electron (4e⁻  ̶ 3c) bond independently.13, 14 The charge distribution on 
each of the ligands attached to the central atom in 4e⁻  ̶ 3c bond is  ̶ 0.5 whilst on that of central 
atom +1.0. In case of organoiodines(III), three molecular orbitals i.e. bonding, anti-bonding and 
non-bonding are produced as a result of interaction of filled 5p orbital of iodine atom and partially 
filled atomic orbitals of two ligands L attached to the central iodine atom but linear to each other. 
The high polarisability of the hypervalent bond is due to the node in the highest occupied molecular 
orbital (HOMO) at central iodine atom. As a result, more electronegative groups tend to occupy 
apical positions whilst least electronegative substituent R bound by normal covalent bond and both 
electron pairs occupy equatorial positions giving distorted trigonal bipyramidal shape to the 
molecule. 
 
Figure 1.3: Pseudotrigonal bipyramidal structure and molecule orbital of the 3c-4e– bond 
On the contrary, bonding in organoiodine(V) compounds, RIL4, having bipyramidal structure, the 
normal covalent bond between organic R substituent and iodine are at apical position whilst four 
ligands L are being accommodated by two orthogonal hypervalent 3c-4e⁻ bonds. Electronegative 
ligands reside at equatorial position while unshared electron pair and organic R substituent take 





Figure 1.4: Square pyramidal structure of ArIL4 
1.3. Classification of organoiodine(III) compounds 
Depending upon the number of carbon ligands attached to the central iodine atom, organoiodines 
can be classified into three classes. 
• Single C-Bond: Iodosyl/iodoso compounds and their derivatives (RIL2, where L represents 
the non-carbon ligands and R can be an aryl/ alkyl/ or CF3. 
• Two C-Bonds: Iodonium salts fall into this category (R2I+L⁻ ). 
• Three C-bonds: (Iodanes having three C-I bonds are generally unstable).  
Apart from the aforementioned categories, some cyclic hypervalent iodine(III) compounds also 
exist derived from o-iodobenzoic acid and are known as benziodoxazole 1.14 and benziodazoles 
1.15.15 All these classes of iodine(III) compounds have found broad applications in organic 
synthesis: (difluoroiodo)arenes 1.8, (dichloroiodo)arenes 1.9, iodosylarenes 1.10, 
[bis(acyloxy)iodo]arenes 1.11a, b, aryliodine(III) organosulfonates 1.13 of which the most 






Figure 1.5: Common classes of organoiodine(III) compounds. 
 
Figure 1.6: Cyclic organoiodine(III) compounds. 
1.4. Hypervalent iodine compounds and their reactivity  
Hypervalent iodine based compounds have received huge interest in the past few decades in 
organic synthesis as versatile and environmentally friendly reagents. One of the fascinating 
developments in this area is the discovery of the catalytic role of iodine in various transformations 
resulting in the formation of carbon-oxygen, carbon-nitrogen and carbon-carbon bonds in organic 
compounds. These transformations having iodine as a catalyst resembles heavy metal catalysed 
reactions but is advantageous due to environmental sustainability and efficient utilisation of natural 





Figure 1.7: General structure and examples of λ3-iodanes.
The aforementioned λ3-iodanes are generally utilised in a wide range of chemical transformations 
such as alkene functionalisation, oxidative dearomatisation of electron rich aromatics, arylation 
reactions, oxidation of sulfides and α-functionalisation of ketones. A detailed explanation of these 
transformations is mentioned in section 1.5.  
Hypervalent iodine(V) reagents, like DMP and IBX are employed in the oxidation of alcohols to 
obtain the corresponding carbonyl compounds. A fluorinated version of IBX has been developed 
by Wirth et al.16 which exhibits greater solubility in common organic solvents and is used in 
oxidative synthetic transformations. Some common λ5-iodanes are mentioned in figure 1.8. 
 




Organo-λ7-iodanes have not been reported yet however, inorganic iodine(VII) reagents exist in the 
form of IF7, H5IO6, and HIO4 (Periodic acids). This dissertation is aimed at λ
3-iodanes mediated 
transformations hence iodine(V) and (VII) compounds will not be discussed further.
The reactivity of trivalent iodine depends upon the number of carbon atoms and ligands attached 
to the central iodine atom. Common reactions of trivalent iodine compounds occur with RIL2 class. 
The two ligands present at apical positions on the central iodine play a pivotal role in performing 
oxidation of several functional groups. These two ligands can act as good leaving groups when the 
highly electrophilic iodine(III) atom is attacked by nucleophiles. This process is called ligand 
exchange. In this process, λ3 iodanyl group leaves with energetically favourable reduction of the 
hypervalent iodide I(III) to normal valence I(I). 
The ligand exchange in λ3-iodanes can follow either associative or dissociative pathway.1, 17 In 
dissociative pathway, one of the two ligands departs from iodane atom to generate dicoordinated 
λ2-iodane 1.1 which is then attacked by appropriate nucleophile to give 1.22. However, associative 
pathway involves the addition of the nucleophile to the iodane first hence generating square planar 
λ4-iodane 1.3 then a ligand is dissociated to form 1.22 from 1.3. (Scheme 1.1) 
 
Scheme 1.1: Possible ligand exchange pathways of λ3-iodanes with nucleophiles Nu- 
In the ligand exchange, energetically favourable reductive elimination of Ar-I happens because of 
the tremendous leaving aptitude of the Ar-I group (millions time better than a triflate ion. ⁻OTf).18 
However, Ar-I can undergo reductive elimination essentially with or without ligand coupling. This 




the aryl group must be present at apical and equatorial position as shown in scheme 1.2.19 The λ3-
iodanes undergo two different kind of reductive eliminations depending upon the fragmentation of 
the hypervalent iodine complex.19-21 This is illustrated in scheme 1.2. 
    
Scheme 1.2: Types of reductive elimination of iodane(III) species. 
1.5. Chiral hypervalent iodine(III) reagents in asymmetric catalysis 
1.5.1. Historic perspective 
Pribram reported the first chiral hypervalent iodine compound in 1907, obtained from the mixture 
of L-tartaric acid and iodosobenzene.22 However structures were not reported at that time. The 
suspected cyclic structures 1.29, 1.30 are shown in the figure 1.9 below. The optical study of these 





Figure 1.9: First chiral hypervalent iodine by Pribram. 
In 1975, Merkushev reported the first chiral amino acid hypervalent iodine(III) derivatives 
however these were not used in  any asymmetric reactions until in 1990s. The first chiral 
hypervalent iodine(V) reagents were reported by Zhdankin in 2000. They used chiral amino acids 
to provide chiral environment for better reactivity and stereocontrol in the oxidation of sulfides to 
sulfoxides.23, 24 
 








1.5.2. Developed strategies to control stereoselectivity and general reactivity patterns 
The strong electrophilic nature of the hypervalent iodine and the leaving groups tendency to leave 
governs the reactivity of hypervalent iodine compounds. Other factors, like nature and number of 
the ligands attached to the central iodine atom also affect and determine its reactivity and 
stereoinduction of the process. In this context, two classes of hypervalent iodine(III) reagents are 
highlighted in figure 1.11.25, 26 The general reactivity mechanism of λ3-iodanes has been explained 
in great detail in scheme 1.1.   
 
Figure 1.11:  Structure classes of hypervalent iodine(III) compounds. 
The reagents of class I are excellent oxidising agents due to the presence of heteroatom ligands 
and effectively permit this reactivity via ligand exchange hence they are extensively employed in 
oxidation reactions. The class II reagents are used in the transfer of one of the carbon substituents. 
The induction of chirality is determined by the chiral environment present around the iodine atom 
generated by heteroatom ligands or non-heteroatom ligands.      
In enantioselective transformations, the design and development of the catalyst is extremely 
important for greater reactivity and higher stereoinduction. Depending upon the type of chirality 
installed on the structures of iodine(III)/(V) reagents, the hypervalent iodine catalysts are divided 





Figure 1.12: Strategies to control stereoselectivity 
The type 1 chiral reagents are oxidised in situ to generate chiral hypervalent iodine(III) reagents. 
The chirality is generally present on one or multiple carbon atoms of the catalyst. Chiral alcohols, 
amines, amino alcohols etc. fall under this category. These heteroatom containing functionalities 
possess a coordinative tendency which helps in stabilising intramolecularly the hypervalent iodine 
intermediate. Many enantioselective transformations employ type I catalysts, however, the 
induction achieved is very limited thus producing desired products in less enantiomeric excess. 
The type II and III structures incorporate axial and planar chirality. These classes involve chiral 
cyclophanes, chiral binaphthyls and chiral biphenyls. Despite reasonable success in terms of 
enantiocontrol using such catalysts, the need for improvement is still present. 
In asymmetric hypervalent iodine mediated oxidations, the most successful and promising strategy 
for enantioselective induction is by using helicity possessing catalysts. In 2010, Fujita27 and 
Ishihara.28, 29 reported C2-symmetric iodine catalysts 1.34, 1.35 bearing conformationally flexible 
chiral lactate and lactamide arms which provided greater enantiocontrol due to the formation of a 
peculiar helical fold 1.36 and 1.37 due to different noncovalent interactions around the iodine 





Figure 1.13: Helical chiral catalysts presenting chirality.  
Sunoj et al.30 reported the role of a resorcinol helical catalyst in the enantioselective 
spirocyclisation of an amide. The formation of the helical fold by the catalyst bearing chiral 
attachments is assisted by a number of non-covalent interactions. The chiral environment provided 
by the formation of helical fold helps to induce enantioselectivity in the products. (Scheme 1.3). 
 




1.6. Applications of chiral hypervalent iodines (CHIs) 
Recently, huge efforts have been made for the employability of enantiomerically pure hypervalent 
iodine reagents in various oxidative transformations generating new C―O, C―N and C―C bonds 
in organic compounds. The catalytic role of hypervalent iodine reagents in transformations like 
oxidation of sulfides to sulfoxides, α-functionalisation of carbonyl compounds, dearomatisation of 
phenols, functionalisation of alkenes, rearrangement reactions and heterocyclisations has been 
extensively studied over the past few decades. In these manipulations, hypervalent iodine(III) 
species are generated in situ by oxidation using stoichiometric amounts of co-oxidant i.e. (m-
CPBA, oxone, selectfluor etc.).31, 32 Interestingly, these catalytic transformations are very similar 
to the transition metal-catalysed reactions, however, possess the advantage of environmental 
sustainability and efficient utilisation of natural resources. 
In 2005, Ochiai and Kita reported independently the first synthesis of hypervalent iodine catalysts 
in situ by using catalytic amounts of iodoarene and stoichiometric amounts of terminal oxidants.32, 
33 The advantages and significance associated with using catalytic amounts of chiral hypervalent 
iodine in different transformations led to the formation of many more catalysts and has opened a 
whole new horizon for researchers. The general catalytic cycle for the formation of iodine(III) 
species in situ is illustrated below (scheme 1.4). 
 




Asymmetric transformations promoted by chiral hypervalent iodine complexes has gained 
considerable importance in the recent years. A few enantioselective reactions mediated by these 
reagents are mentioned below. 
1.6.1. Asymmetric oxidation of sulfides 
Enantiopure sulfoxides are important chiral auxiliaries and useful compounds in their own right. 
Chiral sulfoxides are utilised in a vast number of reactions such as Diels-Alder, Michael addition, 
C-C and C-O bond formation reactions.34 
Imamoto35 and Koser36 demonstrated the first synthetic application of chiral I(III) reagents in the 
oxidation of sulfides 1.44 to sulfoxides 1.45 mediated by 1.43. Corresponding sulfoxides were 
obtained in good yields with selectivities up to 53% ee. (Scheme 1.5) 
 
Scheme 1.5: Oxidation of sulfides to sulfoxides.  
Koser and colleagues36 synthesised iodine(III) dibenzoyl tartrates by reacting 
(diacetoxyiodo)benzene DIB 1.11a with dibenzoyl-L-tartaric acid 1.46. NMR studies proved that 
the chiral iodine compound 1.47 exists in polymeric form. (Scheme 1.6)  
 





Varvoglis et al.37 synthesised a new chiral iodine catalyst by reacting (diacetoxyiodo)benzene 
(DIB) 1.11a with (+)-10-camphorsulfonic acid 1.50 in 80% yield which was then tested by Chen 
and workers38 in the enantioselective oxidation of sulfides. Gratifyingly sulfoxides were obtained 
in good yields but with poor selectivities. 
 
Scheme 1.7: Synthesis of λ3-iodoane by Chen et al.  
Kita et al. reported the first example of asymmetric oxidation of sulfides to sulfoxides mediated 
by hypervalent iodine(V) reagents.39 The best catalytic activity was achieved by using 10 mol% 
of a chiral tartaric acid derivative, 20 mol% cetyltrimethylammonium bromide (CTAB) in the 
presence of iodoxybenzene (PhIO2) in a cationic reversed micellar system to give the sulfoxides 





Scheme 1.8: λ3-iodoane mediated oxidation of sulfides to sulfoxides.  
Later on, the same research group reported the success of the aforementioned transformation by 
using only water as a solvent and MgBr2 to increase the enantioselectivity.
40  
In 1990, Koser and Ray reported the enantioselective oxidation of sulfides 1.48 by using a chiral, 
non-racemic [menthyl-oxy(tosyloxy)iodo]benzenes derived from (1S,2R,5S)-(+)-menthol 1.62 
and (1R,2S,5R)-(–)-menthol. Organic sulfides upon reacting with these reagents in DCM yielded 
optically active (menthyl-oxy)sulfonium tosylates. For instance, methyl p-tolyl sulfides 60 upon 
treatment with 1.62 gave (+)-menthyloxymethyl-p-tolylsulfonium tosylates 1.63 in 92% yield as 
a mixture of diastereomers  (ca 58:42 dr). Recrystallisation of the mixture by DCM/Et2O gave the 
major diastereomer (+)-1.63 which upon hydrolysis by aq. NaOH yielded optically pure (S)-(–)-





Scheme 1.9: λ3-idoane mediated oxidation of sulfides to sulfoxides reported by Koser et al. 
1.6.2. Oxidative α-arylation and α-functionalisation of carbonyl compounds 
Ochiai and colleagues42 reported the synthesis of chiral hypervalent iodine(III) reagents bearing 
axial chirality in 1990 which were then tested in the oxidative arylation reactions of 1,3-diketones. 
The general mechanism of oxidative arylation of the carbonyl compounds is outlined below. 
 
Scheme 1.10: General mechanism of oxidative α-arylation of 1,3-diketones. 
Interestingly, the same researchers in 1999 reported a novel asymmetric arylation reaction of β-
ketoester enolates by employing chiral hypervalent iodine(III) catalysts such as 1.69a and 1.69b. 
(Scheme 1.11). It is believed that the higher reactivity of this salt is because of the nucleofugacity 
of the aryliodonio substituent. The arylation of the in situ produced enolate from 78 with chiral 




enantioselectivities. Despite the low induction achieved, it represented a historical landmark of 
this area. 
  
Scheme 1.11: Chiral hypervalent iodine mediated arylation of cyclic β-ketoesters. 
Another class of chiral iodonium salts has been synthesised by Olofsson and co-workers43 in an 
attempt to provide alternative reagents for oxidative α-phenylation of ketones in higher optical 
yields, however, it appears succinct work has been done in this area as these catalysts were not 
evaluated in such reactions. 
 
Figure 1.14: Chiral hypervalent iodonium salts by Olofsson et al.  
The α-functionalisation reactions of carbonyl compounds mediated by hypervalent iodine species 




and phosphoryloxy44 are among others α-attached to a range of carbonyl compounds. This gives 
rapid access to α-oxygenated carbonyl compounds which could potentially be used in the synthesis 
of complex natural products. The general mechanism for this transformation is outlined below. 
(scheme 1.12). Mechanistically speaking, the process begins with the oxidation of iodobenzene 
1.75 to produce Koser’s reagent 1.12 in situ which is then attacked by the enol 1.76 formed by the 
starting ketone 1.77 to give rise to 1.78 which is followed by the tosylate ion attack to yield the 
corresponding α-tosylated ketone.        
 
Scheme 1.12: General mechanism of Koser’s reagent mediated α-oxytosylation of ketones.  
Wirth and colleagues47 in 2005, reported the first enantioselective α-oxytosylation of 
propiophenone 1.80 mediated by chiral I(III) species 1.81 as stoichiometric reagents. Desired 
products 1.82 were achieved in low yields with 15% ee showing it to be a feasible protocol for the 
synthesis of non-racemic chiral compounds. (Scheme 1.13).   
 
Scheme 1.13: Enantioselective α-oxytosylation of propiophenone. 
Later on, in 2007, Wirth and colleagues48 prepared several chiral iodoarenes catalysts and tested 
them in enantioselective α-oxytosylation of propiophenone derivatives. In particular, they used 10 




stoichiometric oxidant and PTSA (TsOH) to afford the corresponding product 1.82 with 
enantioselectivities up to 39%. 
 
Scheme 1.14: Enantioselective α-oxytosylation of propiophenone 
Wirth and workers49, in 2010, reported the synthesis of a new family of chiral iodoarene catalysts 
and tested them in the enantioselective α-oxytosylation of propiophenone. However products were 
obtained in good yields but with relatively low enantioselectivities i.e. 26%. They decided to 
investigate the newly developed catalysts in the lactonisation reactions of 5-oxo-5-
phenylpentanoic acid 1.84. Unfortunately, the obtained products 1.86 showed extremely low or no 
enantioselectivity. (Scheme 1.15) 
 
Scheme 1.15: Lactonisation reactions of 5-oxo-5-phenylpentanoic acid 
A year later, Zhang et al.50 synthesised a new family of chiral iodoarenes 1.88 possessing a 
spirobiindane scaffold and employed them in asymmetric α-oxytosylation of ketones 1.87 to test 
their chirality inducing ability. As an oxidant, m-CPBA was used along with PTSA (TsOH) to 





Scheme 1.16:  Asymmetric α-oxytosylation of ketones by Zhang et al. 
Moran and Rodriguez51 in 2012 tested their newly developed chiral iodoarene catalysts 1.90a-b 
along with m-CPBA as co-oxidant in the α-oxytosylation of propiophenone 1.80. The product 1.82 
were achieved in good yields and low ee i.e. 18%. The newly synthesised chiral iodoarene catalysts 
were then tried in lactonisation of 5-oxo-5-phenylpentanoic acid 1.84 in the presence of m-CPBA. 
The desired products 1.86 were obtained in good yields and improved enantioselectivities i.e. 51%. 
(Scheme 1.17)  
 
Scheme 1.17:  Hypervalent iodine mediated α-oxytosylation of propiophenone and lactonisation 
of 5-oxo-5-phenylpentanoic acid.  
Legault et al.52 developed new iodooxazoline-based chiral iodoarenes 1.91a-d which were tested 
in the α-oxytosylation of propiophenone 1.80. An improvement in the enantioselectivities were 





Scheme 1.18:  Hypervalent iodine mediated α-oxytosylation of ketones 
Kita et al.53 reported the first example of enantioselective fluorination of β-ketoesters 1.92 
mediated by catalytic system consisting of chiral iodoarene 1.93 as catalyst, HF/Pyridine as 
fluorinating source and m-CPBA as co-oxidant to give α-fluorinated β-ketoesters 1.94 in good 
yields and enantioselectivities. (Scheme 1.19)  
 
Scheme 1.19: Enantioselective fluorination of β-ketoesters catalysed by hypervalent I(III) 
reagents. 
1.6.3. Functionalisation of alkenes 
Asymmetric oxidation of alkenes to achieve multifunctional chiral compounds is considered an 
important transformation in organic chemistry.54 In this regard, various attempts have been made 
to develop new reaction pathways using chiral hypervalent iodine reagents.55-56 The alkenes can 
be activated by the strong electrophilic nature of hypervalent iodine(III) reagents thus enabling a 
vast range of functionalisation reactions. In the literature, diamination57, dioxygenation58, 




been reported. A general mechanism for alkene functionalisation and a few examples of alkene 
functionalisation are mentioned below. The process begins when the iodoarene(I) is converted to 
iodane(III) which upon interaction with Lewis acid or Brønsted acid allows the addition of iodine 
species to the alkene to generate presumed intermediate [A]. This intermediate undergoes 
subsequent SN2 nucleophilic attack to afford the intermediate [B] which undergoes another 
nucleophilic attack to afford the desired product.  
 
Scheme 1.20: Pathway of hypervalent iodine(III) mediated alkene functionalisation reaction.  
1.6.3.1. Dioxygenation of alkenes 
Masson and colleagues63 reported the very first example of enantioselective phosphoryl- and 
sulfonyl- oxylactonisation of 4-pentenoic acid derivatives 1.95 catalysed by chiral iodine(III) 
reagents 1.100. Targeted compounds i.e. phosphoryloxy- 1.103, 1.104 and sulfonyloxy-γ-
butyrolactones 1.101, 1.102 were obtained with good to excellent enantioselectivities in moderate 





Scheme 1.21: Enantioselective phosphoryl- and sulfonyl- oxylactonisation of 4-pentenoic acid 
derivatives. 
Muñiz and co-workers64 reported an asymmetric dioxygenation reaction of styrenes. They used 
chiral catalyst 1.107 bearing an amide group. The NH groups of the chiral arm engage in the 
hydrogen bonding with the acetoxy groups present at the central iodine atom thus resulting in the 
formation of two nine membered rings. As a consequence of hydrogen bonding, a supramolecular 





Scheme 1.22: Enantioselective intermolecular asymmetric diacetoxylation of styrenes. 
 1.6.3.2. Difluorination of alkenes 
Recently, Jacobsen and co-workers65 developed a protocol for the enantioselective catalytic 
difluorination of alkenes 1.109 catalysed by newly prepared chiral iodoarene 1.110 in the presence 
of a fluoride nucleophile and m-CPBA as stoichiometric oxidant. In particular, they prepared α,β-
fluorinated cinnamide 1.111 in good yields with high enantioselectivities. (Scheme 1.23) 
 






1.6.3.3. Oxidative amination of alkenes 
Muñiz and co-workers66 reported the oxidative amination of 1-phenyl allene 1.112 catalysed by 
hypervalent iodine(III) reagents. The obtained propargylic amines 1.114, 1.115 were formed with 
poor enantioselectivity and moderate regioselectivity. Upon coupling iodoarene catalysts with 
triphenylphosphine oxide, the internal regioisomer was obtained with improvement in 
regioselectivity and enantioselectivity. (Scheme 1.24) 
 
Scheme 1.24: Oxidative amination of 1-phenyl allene catalysed by hypervalent iodine(III) 
reagents 
1.6.3.4. Other functionalisations of alkenes 
In 2015, Moran and workers67 reported the cyclisation of N-alkenylamides 1.116 catalysed by 
iodoarenes under oxidative conditions. Five, six and seven-membered rings with a range of 
substitutions were synthesised through this protocol. Preliminary data from the use of chiral 
iodoarenes as pre-catalysts show that enantiocontrol is feasible. A cyclisation forming five 





Scheme 1.25: Oxidative cyclization of N-alkenylamides 1.116 catalysed by chiral iodoarene 
1.117. 
Previous work within our group68 involved the synthesis of a variety of amide catalysts which were 
then employed in the cyclisations of ester analogues 1.119 to give the corresponding products 
1.121 in moderate to good yields with excellent enantioselectivity. Catalyst 1.120 provided the 
highest enantioselectivity, i.e. 87% but in low yield.   
 
Scheme 1.26: Cyclisations of ester analogues 1.119 with amide catalysts 1.120 previously 










Hypervalent iodine reagents find their use in many rearrangement reactions. Numerous 
transformations have been reported in the literature such as ring expansions69, ring contractions70 
and aryl migrations.71 The general mechanism for hypervalent iodine(III) mediated rearrangements 
is illustrated below.  
Mechanistically, iodane(III) species are added to the alkene resulting in the formation of 
intermediate 1.123a. Loss of iodoarene and ligand gives rise to the carbocation intermediate 
1.123b which undergoes rearrangement to yield desired product.    
 
Scheme 1.27: General mechanism of hypervalent iodine mediated rearrangements.  
The first oxidative rearrangement of  α-β unsaturated ketones catalysed by hypervalent iodine(III) 
species was reported by Wirth and workers72 in 2013. They achieved high enantioenriched α-
arylated ketones via enantioselective rearrangement of ketones mediated by chiral iodoarenes. The 
activation of the hypervalent iodine reagent was achieved by the addition of the Lewis acid 
TMSOTf in order to achieve good conversion (instead of a Brønsted acid utilised first in these 





Scheme 1.28: Oxidative asymmetric rearrangement by Wirth and workers. 
Intermediate 1.128 is formed when iodane(III) species are added to the alkene. This intermediate 
is then opened up by a molecule of alcohol (ROH) to give 1.129 which after rotation around a 
single bond undergoes 1,2-aryl migration with inversion of configuration to yield the final product.   
 




Aryl ketone rearrangements catalysed by chiral iodine(III) reagents were reported by Wirth and 
co-workers in 2016.73 They observed that the use of orthoesters(s) promoted the transformation 
and the ketones were converted into aryl ester first and then subsequently afforded desired products 
in reasonably moderate yields and selectivities. 
 
 Scheme 1.30: Chiral iodine(III) reagent mediated aryl ketone rearrangement by Wirth et al. 
Enolate 1.133 attacks iodane(III) species and forms 1.134. Addition of trimethyl orthoformate 
takes place to 1.134 and forms intermediate 1.135. Intermediate 1.135 undergoes 1,2-phenyl 
migration resulting in the loss of iodoarene and the formation of 1.136 which ultimately yields the 





Scheme 1.31: Mechanism of aryl ketone rearrangement catalysed by chiral iodine(III) reagents.  
1.6.5. Oxidative dearomatisation reactions 
Phenol dearomatisation is a powerful strategy in organic synthesis. Phenol and indoles are typical 
(hetero)aromatic test substances which have often been subjected to dearomatisation reactions. 
Numerous methodologies such as oxygenation, dehydrogenation, halogenation, arylation, 
allylation, alkynylation, alkylation and cycloaddition reactions have been developed for this 
purpose.74-81 The advantage associated with dearomatising the (hetero)aromatic substrates is that 
some of their constituent planar carbon atoms can be transformed into stereogenic centres. 
Asymmetric protocols such as using chiral reagents, substrates with chiral appendages and 
catalysts can be used to control the three dimensional configuration of these stereogenic centres.75-
81 
Unarguably, phenols are the most extensively used aromatic species for the dearomatisation due 
to their mildly acidic electron rich aromatic nucleophilic nature. Depending upon the substitution 
patterns and functionalities, phenols can be dearomatised into different reactive species such as 





Figure 1.14: Synthesis of key intermediates via phenol dearomatisation reactions. 
Dearomatisation reactions are greatly affected by the nature of the iodoarene used, reactivity of its 
ligands, nature of the starting phenol (substrate), nucleophilicity of the intervening species leading 
to dearomatisation and also on the reaction conditions like temperature and type of the solvent 
used. In the associative pathway, ArI and leaving group leaves after the nucleophilic attack 
happens hence providing the opportunity of stereocontrol. However, in the dissociative pathway 
phenoxinium ion 1.141a is formed after the departure of ArI and leaving group which subsequently 
undergoes attack by the nucleophile at ortho- or para- position. The main disadvantage of this 
process is the lack of stereocontrol due to the early departure of ArI group. Moreover, the 
dearomatisation via ligand coupling can occur in two possible ways and of course with the 
advantage of stereocontrol. In the first mode of dearomatisation, intermediate 1.138 undergoes 
rearrangement and ligand is added to the ortho- position with the elimination of ArI group at the 
last stage thus providing the opportunity of stereocontrol. In the second case, the addition of the 
ArI group happens at the ortho- position of aromatic ring then the resulting intermediate 1.142a 
undergoes rearrangement causing the addition of the ligand at the ortho- position and subsequent 
departure of ArI group after the dearomatisation has happened. A general explanation of possible 





Scheme 1.32: Possible pathways of phenol dearomatisation catalysed by chiral iodine(III) 
reagents.  
1.6.5.1 Oxidation of phenolic substrates to quinones and quinols 
Yakura and Konishi, in 2007, reported the synthesis of p-quinones 1.144 from p-alkoxyphenols 
1.143 in the presence of catalytic amounts of 4-iodophenoxyacetic acid and Oxone as terminal 
oxidant (Scheme 1.33).82 
 







The reaction of p-substituted phenols 1.145 with catalytic amount of 4-iodophenoxyacetic acid 
and terminal oxidant Oxone afforded p-quinols 1.146 in excellent yields. (Scheme 1.34).83, 84 
 
Scheme 1.34: Catalytic oxidation of p-substituted phenols having an alkyl or aryl group at para 
position. 
1.6.5.2. Oxidative spirocyclisation of aromatic substrates 
Kita and co-workers reported the first example of oxidative spirocyclisation reaction based upon 
the in situ generation of iodine(III) species and m-CPBA as terminal oxidant. The oxidation of 
phenolic substrates 1.147 with m-CPBA in DCM in the presence of 1 mol% p-
[bis(trifluoroacetoxy)iodo]toluene and TFA at room temperature gave desired spirolactones 1.148 
in good yields.85  
 
Scheme 1.35: Catalytic oxidative spirocyclisation reaction of substituted phenol. 
In 2010, Kita et al. reported the catalytic synthesis of biologically active polyspirocyclohexa-2,5-
dienones. The desired product 1.151 was isolated in low yields perhaps due to the oxidation of the 





Scheme 1.36: Synthesis of bioactive polyspirocyclohexa-2,5-dienones via catalytic 
spirocyclisation. 
Ishihara and co-workers reported the enantioselective catalytic spirocyclisation of phenolic 
substrates by employing achiral, non-racemic organic iodides as catalysts. Specifically, naphtholic 
substrates 1.152 underwent oxidative dearomatisation in the presence of chiral iodoarene 1.153 
possessing a rigid spirobiindane backbone to give optically active products 1.154 with high 
enantioselectivities. (Scheme 1.37)87-90  
 
Scheme 1.37: Enantioselective catalytic oxidative spirocyclisation reactions using chiral 
iodoarenes as catalysts. 
The same group reported the synthesis of conformationally flexible C2-symmetric iodoarene 
catalysts and employed them in the aforementioned cyclisation of 1.152 (Scheme 1.38). 
Commonly known as 1st generation Ishihara’s precatalysts, this class of chiral iodoarenes has 
proved to be the best in terms of applicability and enantioselectivity in numerous oxidation 
reactions. This is due to the peculiar structural features which creates an ideal environment around 





Scheme 1.38: Enantioselective catalytic oxidative spirocyclisation reactions using chiral 
iodoarenes as catalysts. 
Kita and workers reported the synthesis of new chiral iodoarene catalyst (R)-1.156 which was 
employed in the oxidative dearomatisation of various phenolic substances 1.155 in the presence of 
mCPBA as terminal oxidant and acetic acid to afford the desired spirolactones 1.157 in excellent 
yields and high enantioselectivities.91 (Scheme 1.39) 
 
Scheme 1.39: Enantioselective catalytic oxidative spirocyclisation reactions using chiral 
iodoarenes as catalysts. 
Ishihara and colleagues92 developed C2-symmetric chiral iodoarenes 1.107a and tested it in the 
tandem enantioselective catalytic dearomatisation of phenolic substrates 1.158 and Diels-Alder 
reaction. The terminal oxidant mCPBA oxidised the chiral iodine(I) 1.107a to chiral iodine(III) 
1.107b in situ which catalysed the reaction to produce cyclohexadienone spirolactones 1.159 





Scheme 1.40: Synthesis of enantiomerically pure cyclohexadienone spirolactones. 
They observed that the use of alcoholic solvents such as HFIP or methanol as additives 
preferentially pushes the reaction towards an associative pathway to yield enantioenriched 
spirocycles. The use of alcoholic additives not only provided better yields of the products but also 
better selectivities. A dramatic increase in the enantioselectivities of the electron deficient 
naphthols was also noted and attributed to use of HFIP.    
Harned and workers in 2013 subjected phenolic substrates 1.161 to asymmetric oxidation in the 
presence of newly developed chiral iodoarene catalyst 1.162 to afford different p-quinols 1.163 





Scheme 1.41: Synthesis of enantiomerically pure quinols 
Ariafard et al.94 investigated the mechanism of a PIDA mediated oxidative phenol dearomatisation 
in 2019 by employing DFT calculations. They found that the formation of the key intermediate i.e. 
dearomatised phenolate iodine(III) 1.161b species is essential for the reaction to proceed. 
Experimental calculations suggested the formation of such kind of intermediate is mandatory for 
the reaction to proceed via associative pathway. It was also observed that in a polar solvent, the 
associative and dissociative pathways can be extremely competitive. They found that by resorting 
to the conventional phenol dearomatisation mechanism, dearomatisation should preferentially take 
place via dissociative pathway only, which was inconsistent with the experiment. A schematic 
explanation is given below. (scheme 1.42) 
The phenol attacks the electrophilic iodine of the PIDA thus forms a key intermediate 1.161b 
which could either undergo associative or dissociative pathway to give the desired product. The 
formation of the hydrogen bonds between the acetoxy group present at the central iodine with the 
molecule of methanol activates the para position for the nucleophilic attack while in the case of 
dissociative pathway acetoxy group present at the iodine leaves resulting in the formation of 1.162 










Chapter 2: Background 
2.1. Genesis of the research project 
2.1.1. Spirocyclisations 
Spirocyclic cyclohexadienones and spirocyclic variants of quinols can be readily obtained by 
organoiodane catalysed oxidative dearomatisation of phenols tethered at their position 2 or 4 to 
form motifs which contain nucleophilic or pronucleophilic centres. Depending upon the nature of 
the nucleophile, spirocyclisations can generally be divided into three classes i.e. oxa-
spirocyclisation, aza-spirocyclisation and carbo-spirocyclisation (scheme 2.1). From here onward 
only oxa- spirocyclisation will be discussed.  
 





In the field of synthetic and medicinal chemistry, the C-O bond is of utmost importance. Generally, 
the formation of a C-O bond involves the nucleophilic substitution or oxidative oxygenation. 
Spiroheterocycles containing C-O bonds are either important building blocks or extensively used 
in the pharmaceutical industry such as Fenspiride 2.8 which is an anti-inflammatory bronchodilator 
used in the treatment of respiratory disorders.96 A variety of spiroheterocyclic derivatives such as 
2.8 has been reported in the literature however only a few examples of natural products containing 
a spiro-oxazoline core such as 2.9a, 2.9b can be found in the literature.97 
 
Figure 2.1:  Examples of oxazaspirocycles.  
Our group has developed a novel protocol for the formation of C-O bond via iodane(III) mediated 
oxidative oxygenation of phenols and naphthols to obtain aesthetically pleasing oxazoline based 
spirocyclic cyclohexaenones and cyclohexadienones (may or may not be chiral). Depending upon 
whether nucleophile “oxygen” connects at phenolic/ naphtholic ortho- or para-, the reaction can 





Scheme 2.2:  Presumed mechanism of para- and ortho- oxygenation of phenols. 
The process starts with the ligand exchange at hypervalent iodine atom forming intermediate 2.10b 
which them undergoes reductive elimination to give cationic derivative of starting phenol 2.11. 
Nucleophilic oxygen attacks the intermediate 2.11 to furnish the dienone 2.12 or 2.14. The 
technique forces the generally nucleophilic phenol to express electrophilic character by the 
reversal of polarity i.e. umpolung.  
We envisaged that spirocyclic frameworks of the type 2.19a,b could be prepared via oxidative 
oxygenation of phenols mediated by iodane(III) species via the aforementioned protocol. 
Accordingly, the first aim of this study was to synthesise oxazoline containing spirocycles similar 
to reported in literature 2.9a,b. We envisaged that a pendant amide would cyclise on to the ring 
after activation by λ3-iodane. A retrosynthetic analysis of this protocol is shown below. 
 
Scheme 2.3:  Retrosynthetic analysis of spiro-oxazoline based spirocycles. 
We envisaged that the oxidation of the natural product 2.9a should produce spiro-oxazoline 2.18. 
The cleavage of C-O bond would give the starting amide 2.17 and upon breaking C-N bond would 
generate the synthons 2.16 and 2.15.   
The same strategy can be applied to access the substituted naphthol amides and to obtain the 
complex spiro-oxazoline based compounds which could be racemic or enantiopure. The spirocycle 
2.23 would form the corresponding amide after C-O bond breakage. We envisaged that the amide 






Scheme 2.4:  Retrosynthetic analysis of naphthol based spiro-oxazoline. 
The third aim was to develop chiral hypervalent iodine precatalysts bearing mono- or di-, 
carbamate, urea, lactate, and amide appendages which could be converted into the corresponding 
I(III) catalysts in situ for the dearomatisation reactions of naphthol amides to yield enantiopure 
spirocycles. It was hypothesised that the formation of the helical fold by the catalyst bearing chiral 
attachments due to a number of non-covalent interactions would generate a chiral environment due 




Chapter 3: Results and discussions 
3.1. Synthesis of phenolic amide substrates 
A range of substituted amides containing electron withdrawing, electron donating, heteroaromatic 
ring and neutral groups were synthesised using two different literature procedures98, 99 by reacting 
4-hydroxybenzylamine 2.16 with commercially available acyl chlorides to afford substituted 
amides in moderate to good yields. Amide 3.30 was synthesised using a reported literature 
procedure.100 
 
Scheme 3.1: Synthesis of substituted phenolic amides. 
Amides 3.1 to 3.11 containing methoxy-, chloro-, bromo-, methyl- and nitro- groups were prepared 
in moderate to good yields according to the aforementioned procedures. Likewise, amides 3.12 to 
3.16 containing fluoro- and trifluoromethyl groups were obtained in good to excellent yield. Next, 
we focused our attention on the preparation of amides containing heterocyclic functionalities like 
indole, pyrrole, furan, thiophene and pyridyl group 3.17 to 3.23. Finally, amides 3.24 to 3.30 
containing different alkyl substituents were prepared in good to excellent yield. The main aim to 


















3.2. Synthesis of naphtholic amide substrates 
A range of naphtholic amides for dearomatisation reactions were synthesised in good to excellent 
yields using literature procedure.101 In particular, naphthol or naphthol derivative 3.31a, b were 
reacted with commercially available N-(hydroxymethyl)benzamide 3.32a and N-
(hydroxymethyl)acetamide 3.32b in dry ethanol and concentrated sulfuric acid as catalyst to afford 
the corresponding naphthol amides 3.33a-d in good to excellent yields.   
 
Scheme 3.2: Synthesis of substituted naphthol amides.   
 
Figure 3.2:  Synthesised naphtholic amides for dearomatisation reactions. 
Mechanistically speaking, the unsaturated N-(hydroxymethyl)amide upon protonation by 
concentrated sulfuric acid loses a water molecule resultantly forming an iminium ion intermediate 
A which undergoes subsequent attack by the π-electrons of the naphthol and produces the desired 





Scheme 3.3: Procedure for the synthesis of substituted naphthol amides.   
3.3. Oxidative dearomatisation reactions of phenolic substrates 
Newly synthesised phenolic amides were then tested in oxidative dearomatisation reactions. 
Initially, we started our investigation with the amide 3.1 and commercially available iodane(III) 
reagents in stoichiometric quantities. The reaction was carried out in fluorinated solvent i.e. TFE. 
The results of our investigation are summarised below. 
 




Yields were determined by adding 1,3,5-trimethoxybenzene as internal standard. N.D. = No development 
Table 1: Optimisation of reaction conditions.  
Amide 3.1 gave the desired spirocycle in 60% yield in the presence of freshly prepared Koser’s 
reagent in TFE (table 1, entry 5) at 50 oC after one hour. However desired product was not obtained 
when the reaction was carried out using PIFA in TFE at ‒ 10 oC (table 1, entry 1), only starting 
material was recovered. Repeating the same reaction at 50 oC gave only 14% product while the 
majority of the starting material was recovered (table 1, entry 2). Spirocycle 3.37 was obtained in 
31% and 45% yields in the presence of PIDA and Koser’s reagent when the reaction was carried 
out at 50 oC and ‒ 10 oC respectively (table 1, entry 3 & 4).    
Later on, we focused our attention to develop a catalytic version of this transformation. The aim 
of this was to generate hypervalent iodine(III) species in situ which would catalyse the reaction 
and give the desired spirocycle. The transformation was carried out at different temperatures, in 
the presence of different iodoarenes and solvents to obtain the corresponding spirocycle of amide 
3.1.
Entry Reaction conditions Yield 
1 PIFA (1.5 equiv.), TFE, ‒ 10 oC, 1hr N.D. 
2 PIFA (1.5 equiv.), TFE, 50 oC, 1hr 
14 % Product 
Mostly SM 
3 PIDA (1.5 equiv.), TFE, 50 oC, 1hr 
31 % Product 
No SM 
4 Koser’s Reagent (1.5 equiv.), TFE, ‒ 10 oC, 1hr 
45 % Product 
No SM 
5 Koser’s Reagent (1.5 equiv.), TFE, 50 oC, 1hr 





3.3.1. Screening of iodoarenes in MeCN  
 
Scheme 3.5: Oxidative dearomatisation reaction of amide 3.1 in acetonitrile. 





















































‒ MeCN 60 oC 16h Traces 
Table 2: Optimisation of reaction conditions in MeCN mediated by a variety of iodoarenes. N.D. = No development 
Earlier on we tried the conditions reported in the literature90 to obtain the spirocycle 3.37 but no 
development was made (table 2, entry 1). So, we then attempted the same cyclisation without 




iodoarenes were tested as precatalysts in acetonitrile and terminal oxidant mCPBA (table 2, entries 
1-9). Our experimentation revealed that only 3-iodotoluene and 2-iodotoluene yielded the targeted 
product in trace amounts. (Table 2, entries 7 & 9). However no significant development was noted 
in the case of other experiments.          
3.3.2. Screening of iodoarenes in DCM 














DCM RT 16h 7% 
Table 3: Optimisation of reaction conditions in dichloromethane. 
We tested the amide 3.1 cyclisation reaction (scheme 3.5) in halogenated solvent i.e. 
dichloromethane. Iodoarene precatalysts like 5-iodo-m-xylene and 4-iodotoluene were employed 
in the presence of oxidant mCPBA in an attempt to obtain the desired spirocycle. Unfortunately, 
extremely low yields were observed in both cases (table 3, entry 1 & 2). It was also noted that the 
increase of catalyst loading (table 3, entry 2) did not help much. 
3.3.3. Screening of iodoarenes and oxidants in fluorinated solvents 
 
Scheme 3.6: Oxidative dearomatisation reaction of amide 3.1 in fluorinated solvents. 
In the light of above experimental observations, we concluded that a polar protic solvent such as 
TFE or HFIP is needed for the aforementioned transformation to give the desired spirocycle in 
reasonable yields. We began testing different iodoarenes as precatalysts in the presence of oxidant 
mCPBA in order to obtain the desired product. Gratifyingly, we obtained the desired spirocycle in 




that elevated temperature proved detrimental for the reaction and gave the desired product in 
extremely low yield (table 4, entry 4). Increase in catalyst load significantly increased the rate of 
reaction and resulted in enhanced yield (table 4, entry 5).        








































































































HFIP RT 16h 32% 
Table 4: Optimisation of reaction conditions in fluorinated solvents.  
Spirocycle 3.37 was formed in low to moderate yields in the presence of trifluoroethanol (TFE) 
mediated by different iodoarene precatalysts. So we decided to test our reaction in 
hexafluoroisopropanol (HFIP). Due to its unique features, HFIP is usually described as a polar, 
low-nucleophilic solvent with high ability to stabilize aromatic radical cations. Pioneering work 
from Kita showed the powerful oxidising ability of hypervalent iodine compounds in combination 
with HFIP.102     
Gratifyingly, smooth dearomatisation cyclisation occurred in the presence of 4-iodotoluene 
precatalyst and mCPBA as oxidant and gave the spirocycle in 75% yield (table 4 entry 9). 
Changing the oxidant from mCPBA to Oxone, Selectfluor or Peracetic acid led to lower yields 
(table 4 entries 10-12). Substituting iodoarene for other iodoarenes also proved detrimental to the 
reaction (table 3 entry 6 & 16). However using 20 mol % of iodobenzene surprisingly gave the 
product in elevated yield (table 4 entry 15). The use of 4-iodotoluene was preferred over 
iodobenzene as it exists in solid form making the measuring and handling easy. Based upon the 
optimised conditions, oxidative dearomatisation cyclisation of phenolic amide 3.1 was best 
achieved when 4-iodotoluene and mCPBA were used as precatalyst and oxidant respectively in 
HFIP which turned out to be the best solvent for this transformation.     
Having optimised the reaction conditions, a range of substituted phenolic amides were subjected 
to oxidative dearomatisation spirocyclisation reactions mediated by 4-iodotoluene (20-40 mol %) 





Scheme 3.7: Phenol dearomatisation mediated by 4-iodotoluene.  
 
 
Figure 3.3:  Synthesised substituted spirocycles containing neutral, electron donating and electron 
withdrawing groups.   
A range of substituted spirocycles containing phenyl-, tolyl-, nitro-, dinitro-, bromo-, chloro-, and 
methoxy- groups were prepared from corresponding amides in moderate to good yields. It was 
observed that all the starting material was consumed after 16hr and no amount of starting material 
was noticed in the crude NMR of the reaction mixture. Compound 3.37 was obtained using 20 and 
40 mol% 4-iodotoluene in 67% and 71% isolated yields. However, poor purification techniques 
led to the loss of the product and hence decrease in the yield of compounds 3.40, 3.41 and 3.44. 
Amides containing fluoro- and trifluoromethyl- groups underwent smooth oxidative 





Figure 3.4:  Synthesised oxazoline spirocycles containing fluoro- and trifluoromethyl- groups.  
We next planned to test heterocyclic amides in the dearomatisation reactions. Gratifyingly, smooth 
dearomatisation was observed. It was noted that the simultaneous addition of the oxidant i.e. 
mCPBA led to the lower yields in case of spirocycles. However adding mCPBA in portions over 
4 hours gave augmented yields in case of spirocycles 3.53, 3.54 and 3.57. Full consumption of the 
starting material was observed in case of spirocycles 3.54 and 3.58 however a pure sample of the 
product could not be obtained due to the highly unstable nature of the spirocycle.          
 




Newly developed dearomatisation conditions were then applied to amides possessing alkyl and 
cyclic alkyl substituents. Spirocycle 3.59 was achieved quantitatively however a pure sample of it 
could not be obtained due to the stability issues. Spirocycle 3.60 was obtained in 41% isolated 
yield without the detection of any starting material in the crude NMR of the reaction mixture. 
Spirocycle 3.61 was not formed however only starting material was observed in the reaction 
mixture. It is believed that the presence of three chloride substituents affected the nucleophilicity 
of carbonyl oxygen due to their strong electron withdrawing ability thus making the nucleophile 
less reactive for intramolecular attack to furnish the desired spirocycle. It was also noted that the 
amides possessing cyclic alkyl substituents were not the ideal substrates for this transformation as 
3.62 was obtained in extremely low yield while spirocycle 3.63 was not observed in the crude 
NMR of the reaction mixture at all. A complex proton NMR of the reaction mixture was obtained 
pointing towards the potential instability of the product or change in the reactivity of the amide. 
Further attempts to optimise the reactions conditions for the cyclic alkyl substituents were deemed 
unnecessary at this point.  
 




3.3.4. Attempted synthesis of natural product precursor  
We subjected the amide 3.30 to the conditions required for the spirocyclisations of phenolic amides 
to obtain the desired natural product precursor 2.18. Sadly, only a trace amount of the expected 
product was noticed in the crude 1H-NMR. The reaction was not further optimised. 
 
Scheme 3.8: Attempted synthesis of natural product precursor.  
3.3.5. Effect of substituent on the reaction 
In order to investigate the effects of the substituent on the reaction, we decided to structurally 
amend the model substrate 3.1. For this purpose, we synthesised amide 3.67 from the commercially 
available amine 3.65 and benzoyl chloride 3.66 (scheme 3.9) in order to have a substituent on the 
cyclohexadienone ring.98 We also envisaged that the presence of the proton of the hydroxyl group 
may or may not be necessary for the reaction to proceed. 
     
Scheme 3.9: Synthesis of substituted amide 3.67.  
To test this hypothesis, we subjected the newly synthesised amide 3.67 to the conditions required 
for the dearomatisation (scheme 3.10). Ungratifying, the reaction failed to produce the expected 
product and almost all the starting amide was recovered. Our investigation proved that for the 
dearomatisation to happen smoothly, the presence of the proton of the phenolic group is mandatory 





Scheme 3.10: Attempted dearomatisation of amide 3.67. 
We turned our attention to investigate whether the reaction proceeds via radical pathway or 
associative/dissociative pathway. For this purpose, we subjected amide 3.5 to the typical 
dearomatisation conditions and added free radical inhibitor TEMPO (2,2,6,6-
Tetramethylpiperidin-1-yl)oxyl (scheme 3.11). Our investigation revealed that the reaction did not 
follow a radical pathway and proceeded as usual to form the desired spirocycle in 66% yield 
without forming any side product or the remaining starting material. 
 
Scheme 3.11: Dearomatisation of amide 3.5 in the presence of TEMPO. 
Having known that the para- oxidative dearomatisation of the phenols is indeed feasible, we 
decided to apply the developed protocol for the dearomatisation of substituted 2-
hydroxybenzamides. In order to do so, we prepared the requisite amide according to the 
aforementioned conditions and subjected it to the dearomatisation reaction mediated by 4-
iodotoluene and mCPBA as terminal oxidant (scheme 3.12). Sadly, the targeted spirocycle could 
not be obtained whilst a complicated mixture was obtained. We tried the same reaction again but 
instead of using HFIP we resorted to use dichloromethane as solvent. However, no noticeable 
development could be made. Further attempts to develop the conditions for this transformation 





Scheme 3.12: Dearomatisation of amide 3.71 in the presence of TEMPO. 
We hypothesised that the iodoarene(I) 3.74 undergoes oxidation by the terminal oxidant mCPBA 
to generate iodane(III) 3.76 species in situ which is then attacked by the nucleophilic hydroxyl 
group of the phenol 3.1 to produce intermediate A (scheme 3.13). The intermediate A is capable 
of following either dissociative or associative pathway to form the desired spirocycle. In the 
associative pathway, intramolecular attack of the nucleophile happens after which ArI group and 
ligand depart to produce the spirocycle. However, in the dissociative pathway the ArI group has 
already left forming the cationic intermediate B which after the nucleophilic attack generates the 
corresponding spirocycle 3.37. The plausible mechanism of the phenol dearomatisation is 





Scheme 3.13: Plausible mechanism of phenol dearomatisation. 
3.4. Oxidative dearomatisation reactions of naphtholic substrates 
The newly developed dearomatisation strategy could be applied to the substituted naphthol amides 
to obtain oxazoline based spirocycles. We started our investigation with the amide 3.33a and 
subjected it to the conditions which would produce spirocycle. A range of solvents, iodoarenes 
and oxidants were tested during this process. The results of our investigation are summarised 




 3.4.1. Optimisations in MeCN  
 
Scheme 3.14: Dearomatisation of amide 3.33a in acetonitrile. 
Entry Oxidant Iodoarene Acid Solvent Time 
Yield 
(Crude) 
1 m-CPBA (2.2 eq.) 
2-Iodoanisole 
20 mol% 
― MeCN 16h 35% 
2 m-CPBA (2.2 eq.) 
2-Iodoanisole 
20 mol% 
PTSA MeCN 16h 28% 
3 Selectfluor (3 eq.) 
2-Iodoanisole 
20 mol% 
― MeCN 16h N.D. 







5 m-CPBA (2.2 eq.) 
2-Iodoanisole 
40 mol% 
― MeCN 16h 48% 
Crude yields were determined by adding 1,3,5-trimethoxybenzene as internal standard. N.D. = No development 
Table 5: Optimisation of the reaction in acetonitrile.  
We initiated our experimentation with amide 3.33a, 2-iodoanisole as the standard iodoarene in 
acetonitrile as the standard solvent. It was noted that the use of acids such as AcOH, PTSA as 
additives led to diminished yields (table 5, entry 2). The utilisation of dual solvent system also led 
to diminshed yields (table 5, entry 4). Moreover, no noticeable development was made by changing 
the oxidant to Selectfluor (table 5, entry 3). Increasing the catalyst loading from 20 mol% to 40 
mol% had a favourable influence on the rate of the reaction and gave augmented yield (table 5, 
entry 5). Keeping in view the results, we decided to change the iodoarene to 4-iodotoluene and the 




3.4.2. Optimisations in fluorinated solvents  
 
Scheme 3.15: Dearomatisation of amide 3.33a in fluorinated solvents. 
Entry Oxidant Iodoarene Solvent Time 
Yield 
(Crude) 
1 m-CPBA (3 eq.) 
2-Iodoanisole 
20 mol% 
TFE 16h 39% 
2 m-CPBA (2.2 eq.) 
4-Iodotoluene 
20 mol% 
HFIP 16h 46% 
3 m-CPBA (2.2 eq.) 
4-Iodotoluene 
40 mol% 
HFIP 16h 75% 
4 Selectfluor (2.2 eq.) 
4-Iodotoluene 
20 mol% 
HFIP 48h 32% 
5 Oxone (2.2 eq.) 
4-Iodotoluene 
20 mol% 
HFIP 48h N.D. 
6 




HFIP 6 days 52% 





6 days N.D. 





6 days 28%. 
9 H2O2 (2.2 eq.) 
4-Iodotoluene 
20 mol% 
HFIP 6 days Traces 









11 Koser’s reagent (1 equiv.), HFIP, 16hr, RT N.D. 
12 Koser’s reagent (1 equiv.), HFIP, 8hr, reflux <5% 
Crude yields were determined by adding 1,3,5-trimethoxybenzene as internal standard. N.D. = No development 
Table 6: Optimisation of the reaction in acetonitrile.  
It was observed that changing the solvent to TFE led to an increase in the product yield when the 
reaction was mediated by 2-iodoanisole and mCPBA (table 6, entry 1). Replacing 2-iodoanisole 
with 4-iodoanisole in HFIP provided a significant increase in the product yield while an increase 
in the catalyst loading (from 20 mol% to 40 mol%) gave the product in the highest yield (table 6, 
entries 2-3). It was also noted that changing the oxidant from mCPBA to Selectfluor, Oxone, 
Peracetic acid and H2O2 proved detrimental for the reaction (table 6, entries 4-10). It was also 
found that the use of commercially available iodane(III) species such as Koser’s reagent in HFIP 
failed to provide the desired results (table 6, entries 11-12). 
Having optimised the reaction conditions, different substituted naphtholic amides were subjected 
to oxidative dearomatisation spirocyclisation reactions mediated by 4-iodotoluene (20 mol %) and 
mCPBA as oxidant in HFIP. The obtained novel spirocycles are mentioned below. 
 
Figure 3.7: Naphthol amide derived spirocycles. 
A pure sample of the spirocycle 3.79 could not be obtained due to the instability of the product. 
3.4.3. Investigation of the reaction mechanism 
We focused our attention to investigate whether the reaction proceeds via radical pathway or 
associative/dissociative pathway. For this purpose, we subjected amide 3.33a to the typical 




Tetramethylpiperidin-1-yl)oxyl and galvinoxyl, free radical. Our investigation revealed that the 
reaction did not follow a radical pathway and proceeded as usual to form the desired spirocycle in 
70% (with 40 mol% 4-iodotoluene) and 37% (with 20 mol% 4-iodotoluene) yield respectively 
without forming any side product. 
 
Scheme 3.16: Dearomatisation of amide 192a in the presence of free radical inhibitors. 
Mechanistically speaking, the iodoarene(I) undergoes oxidation by the terminal oxidant mCPBA 
to generate iodane(III) species in situ which is then attacked by the nucleophilic hydroxyl group 
of the naphthol to produce intermediate C. The intermediate C could either follow dissociative or 
associative pathway to give the targeted spirocycle. In the associative pathway, intramolecular 
attack of the nucleophile happens after which ArI group and ligand depart to produce the spirocycle 
with the advantage of stereocontrol. However, in the dissociative pathway the ArI group has 
already left forming the cationic intermediate D which after the nucleophilic attack generates the 
corresponding spirocycle 3.77 in a racemic manner. The plausible mechanism of the naphthol 





Scheme 3.17: Plausible mechanism of naphthol amide cyclisation.  
3.5. Functionalisation of the spirocycles 
The synthesised amides were subjected to the functionalisation reactions. Freshly synthesised 
spirocycles 3.41 and 3.77 were reacted with a (1.6 M) solution of methyllithium in hexanes (MeLi) 
in anhydrous tetrahydrofuran at  ̶ 78 °C. Gratifyingly, the corresponding spiro-alcohols were 
obtained in good to excellent yields with 5:1 dr in both cases. (Scheme 3.18) In the case of 
compound 3.82, the major diastereomer showed the interaction (nOe) between the protons of the 
methyl group and methylene group of the oxazoline ring however no such interaction was observed 





Scheme 3.18: Reaction of spirocycle 3.41 and 3.77 with methyl lithium. 
We tried to reduce the spirocycle 3.41 using Pd/C in an admixture of ethyl acetate and methanol 
in the presence of hydrogen gas using a balloon but sadly the reaction did not work and almost all 
the starting material was recovered. Next, we carried out a conjugate addition to the spirocycle 
3.41 by using cuprous iodide and methyllithium but sadly this reaction also did not work. 
3.6. Synthesis of six membered spirocycles 
Having confirmed that the dearomatisation of phenols and naphthols via hypervalent iodine 
species is feasible to construct five membered spirocycles, we decided to prepare another class of 
amides by reacting tyramine 3.83 with commercially available acyl chlorides using the 
aforementioned procedure.99 Amides 3.84a-c were obtained in good to excellent yield when 
appropriate acyl chlorides were reacted with tyramine 3.83.  These amides would generate six 





 Scheme 3.19: Synthesis of substituted amides 3.84a-c. 
Gratifyingly, newly prepared amides underwent smooth dearomatisation to produce the 
corresponding six membered spirocycles when subjected to the already developed dearomatisation 
conditions. Spirocycle 3.85a was isolated in 51% yield and spirocycle 3.85b was achieved in 81% 
isolated yield. However, it was noted that the starting amide 3.84c was fully converted to 3.85c 
but a pure sample could not be obtained as the compound decomposed during the purification. 
(Scheme 3.20) 
 
Scheme 3.20: Synthesis of substituted amides 3.84a-c. 
 
 




3.7. Summary   
In conclusion, the synthesis of five membered spiro-oxazolines and six membered spirocycles via 
oxidative dearomatisation of phenol and naphthol amides mediated by 4-iodotoluene as catalyst 
and mCPBA as terminal oxidant. Different iodoarenes, catalysts, and solvents were scanned, 
however, 4-iodotoluene and mCPBA provided the best results in hexafluoroisopropanol (HFIP). It 
was observed that altering the oxidant, iodoarene and solvent led to diminished yields in most 
cases. The stoichiometric and catalytic versions of the cyclisation were also successfully 





















Chapter 4: Enantioselective oxidative cyclisation of naphthol amides 
Having confirmed that the oxidative dearomatisation of naphthols with hypervalent iodine 
compounds is indeed feasible, our attention refocused upon the development of an enantioselective 
variant of the reaction. To the best of our knowledge, no such protocol has been reported before in 
the literature.   
Initial experiments aiming to achieve the transformation of interest focused upon the utilisation of 
Ishihara type C2-symmetric chiral iodoarenes in the presence of mCPBA as terminal oxidant. 
These kind of iodoarenes had already been used for the enantioselective cyclisation of carboxylic 
acids and can readily be synthesised.90 The preparation of C2-symmetric chiral iodoarenes started 
with the iodination of the resorcinol103 4.1 followed by Mitsunobu reaction of 4.2 with (-)-(S)- 
ethyl lactate, 4.3. The obtained ester 4.4 was then subjected to base hydrolysis to furnish the diacid 
4.5 which was elaborated to 4.6 via the acid chloride. 
 
Scheme 4.1: Synthesis of C2-symmetric iodoarene 4.6 
Similarly, iodination of 4.7 formed 4.8 104 which after reaction with (S)-methyl-2-hydroxy-3-





Scheme 4.2: Synthesis of C2-symmetric iodoarene 4.10. 
4.1. Screening of conditions 
At the outset of the project only iodoarene 4.6 and 4.10 were known. So we decided to develop 
the conditions for the enantioselective dearomatisation of naphthol amide 3.33a using these 
iodoarenes and oxidants. 
 
Scheme 4.3: Enantioselective dearomatisation of naphthol amide 3.33a by different C2-symmetric 
iodoarenes. 
















































̶  20 °C 18h 36% 14 
 
a 
Isolated yields after column chromatography. 
b 
Enantiomeric excess were determined by using chiralpak IB 
column (Petroleum ether:Isopropanol 80:20, Flow rate 1 mL/ min). 
c Complex reaction mixture was obtained.  




Our experimentation showed that the increase in the catalyst load improved the overall yield of 
the reaction however a significant decline was observed in the selectivities. It was also noted that 
the use of alcoholic solvents like MeOH and EtOH had favourable influence on the rate of reaction 
significantly (table 7, entries 1-2 and 5). Keeping in view these results, we decided to decrease the 
catalyst load to 10 mol%, oxidant to 1.2 equiv. and replaced acetonitrile with a mixture of solvents 
i.e. DCM:Methanol (3:1) while leaving the reaction mixture to stir at  ̶ 20 °C for 18 hours. To our 
delight, enantioselectivity considerably improved but at the expense of the rate of the reaction. 
(table 7, entry 5).    
Having confirmed that the enantioselective oxidative dearomatisation of the naphthols is indeed 
feasible we decided to prepare our own novel iodoarene precatalysts. The aim to develop these 
iodoarenes was to test their oxidising potential in the oxidative dearomatisation reactions under 
various conditions.     
4.2. Synthesis of novel iodoarenes 
4.2.1. Synthesis of C1 & C2 symmetric iodoarenes bearing chiral carbamate appendages 
With a view to develop novel chiral iodoarene precatalysts, the focus was shifted on the preparation 
of C2-symmetrical chiral iodoarenes possessing optically active lactate motifs. Initially, we 
synthesised C1-symmetrical chiral iodoarenes bearing carbamate appendages. These were 
synthesised by coupling 2-iodoisocyanatobenzene 4.12 with commercially available optical 
lactates 4.19. 2-Iodoisocyanatobenzene 4.12 was prepared from 2-iodoaniline 4.11 following 
literature procedure.105 The same methodology was used to prepare C2-symmetrical chiral 
iodoarenes. For this purpose, diisocyanatoiodobenzene 4.18 prepared from 2-iodoisophthalic acid 
4.17 following the literature procedure and was subsequently coupled with different lactates in the 
presence of CuI in DMF. However, the synthesis of diisocyanatoiodobenzene 4.18 came with 
challenges. The synthesis of 4.18 can be achieved through two different routes as explained in 
scheme 4.4. 
At the outset of the research, we tried to access the diisocyanatoiodobenzene 4.18 via route A. 2,6-
Dinitroiodobenzene 4.18 was obtained in good yield by iodination of commercially available 2,6-
dinitroaniline 4.13.106 Several methods were tried for the reduction of 4.13 to obtain 4.14, however, 





Scheme 4.4: Synthesis and retrosynthetic pathways to access 4.12 and 4.18. 
 
Scheme 4.5: Preparation and reduction of 4.14. 
Entry No. Reactant Conditions Product 
1 
4.14 
Fe Powder/CaCl2, EtOH/H2O, 60 
oC, 1h N.D. 
2 Fe Powder/NH4Cl, EtOH/H2O, 85 
oC, 4h N.D. 
3 NaBH4/Charcoal 
H2O-THF (1: 0.5ml), reflux, 50-60
 oC, 2h 
N.D. 
4 10% Pd/C, H2 gas 
Dry methanol, overnight, RT 
N.D. 
5 10% Pd/C, N2H4.H2O (20 equiv.), Dry methanol, 
Reflux, 90 oC, 1h 
N.D. 
6 HSiCl3, DIPEA, Dry MeCN, 0 
oC to RT. N.D. 
7 Iron Powder, AcOH, 
60 oC, 2h. 
Traces 




Partial reduction along with dehalogenation was observed upon using iron powder in acetic acid 
(table 8, entry 7,). However no product was observed in all other cases, whatsoever. 
In order to obtain diisocyanatoiodobenzene 4.18, route B was adopted. Commercially available 2-
aminoisophthalic acid 4.16 was used to obtain 4.18 directly. In particular, 2-aminoisophthalic acid 
was converted into 4.17 which was then used in the presence of triethylamine and 
diphenylphosphory azide (DPPA) in dry benzene to produce 4.18.114 Unfortunately, the desired 
product could not obtained.  
 
Scheme 4.6: Attempted synthesis of 4.18. 
Instead of obtaining 4.18 directly, an indirect route was followed as shown in scheme 4.7. For this 
purpose, 2-aminoisophthalic acid 4.16 was iodinated to obtain 2-iodoisophthalic acid 4.17 in 80% 
yield.115 Upon refluxing 4.17 in SOCl2 for 2 hours the corresponding acid chloride was generated 
which upon azidation and subsequent refluxing in toluene for 3 hours afforded 4.18 almost 
quantitatively.  IR analysis confirmed the presence of isocyanate peak confirming the formation 
of 4.18. 
 
Scheme 4.7: Indirect synthesis of 4.18. 
After successfully synthesising 4.12 and 4.18, we then synthesised different C1 and C2-symmetric 






Scheme 4.8: Synthesis of C1 and C2-symmetric iodoarene precatalysts possessing chiral 
carbamate appendage.  
It was noted during the purification of these carbamates that they were intolerant of silica and 
started disintegrating during the purification process. We also synthesised other carbamates 
following a different procedure.116, 139 For this purpose, (S)-2-amino-3-phenylpropan-1-ol 4.26 was 
converted to 4.27a and 4.27b and then coupled with 4.18 to give corresponding carbamates 4.28a, 







Scheme 4.9: Synthesis of C2-symmetric iodoarene precatalysts possessing chiral carbamate 
appendage. 
4.2.2. Synthesis of C1 & C2-symmetric iodoarenes bearing chiral urea appendages 
Keeping in view the instability of the carbamates, we decided to prepare another class of iodoarene 
precatalysts possessing an oligourea foldamer. Oligoureas are well known for their helicity.117 The 
main idea for the synthesis of iodourea based catalysts was that the weak interactions between the 
chiral arms with either the electrophilic I(III) centre or with the ligands on I(III) would supply a 
suitable chiral environment by forming a helical supramolecular fold for chiral induction. At the 
outset of the project we prepared C1-symmetric iodoarenes 4.29 and 4.31 (scheme 4.10) having 
chiral urea arm but later we decided to synthesise C2-symmetric iodoarenes as well (scheme 
4.13).118 
 




The reaction of 4.12 with different chiral amine 4.26 and 4.30 in anhydrous THF produced various 
C1-symmetric urea-iodoarenes 4.29 and 4.31. Specifically speaking, (S)-2-amino-3-phenylpropan-
1-ol 4.26 upon reaction with 4.12 produced 4.29 in 95% yield. Likewise, (S)-1-phenylethan-1-
amine 4.30 reacted with 4.12 in THF to afford 4.31 in 96% yield. We also made two other 
marginally structurally different iodoarenes (4.34 and 4.36) bearing a chiral urea arm. Benzyl-L-
alaninate 4.32 and methyl-L-leucinate upon reaction with 4.12 gave 4.34 and 4.36 in 88% and 73% 
yield respectively. 118  
 
Scheme 4.11: Preparation of C1-symmetric iodoarenes having chiral urea appendages.  
After successfully preparing different C1-symmetric urea based iodoarenes we refocused our 
attention to develop C2-symmetric urea based iodoarenes. Different commercially available amino 
acid or aminoalcohols were reacted with diisocyanatoiodobenzene 4.18 to achieve the desired 
ureas. Specifically speaking, bis-urea 438a and 438b were synthesised by the reaction of 
diisocyanatoiodobenzene 4.18 with (S)-2-aminopropan-1-ol and (S)-2-aminobutan-1-ol in 81% 





Scheme 4.11: Preparation of C2-symmetric iodoarenes possessing chiral urea appendages.  
Similarly, bis-ureas 4.38c and 4.38d were synthesised by the reaction of diisocyanatoiodobenzene 
4.18 with (S)-2-amino-3-phenylpropan-1-ol and (1R,2R)-2-amino-1,2-diphenylethan-1-ol in good 
yields. The reaction of (1R,2S)-2-amino-2,3-dihydro-1H-inden-1-ol and L-phenylalanine with 
diisocyanatoiodobenzene 4.18 produced bis-ureas 4.38e and 4.38f in good yields. Bis-urea 4.40 
was synthesised via a different method. We started with the protection of the amino group of (S)-
2-amino-3-phenylpropan-1-ol 4.26 then subjected the obtained crude to the conditions which 
would allow o-acylation.119, 120 Gratifyingly, we obtained the desired compound 4.39 in good yield. 
Next, the compound 4.39 was stirred in 2ml of TFA overnight to obtain the hydrochloride salt of 
the desired compound 4.39a which upon coupling with 4.18 generated the targeted bis-urea in 49% 





Scheme 4.12: Synthesis of C2-symmetric iodoarenes 4.40.  
We refocused our attention on the incorporation of another urea moiety into the already 
synthesised bis-ureas. For this purpose, we started our investigation by choosing 4.38c as the 
model substrate and subjected it to Mitsunobu conditions.122 We tried different procedures123, 124 
to remove the phthalide group from 4.38 however none worked. In each case a complex mixture 
was obtained which did not contain either starting material or the product. Hence 4.40b could not 
be obtained. (Scheme 4.13) 
 
Scheme 4.13: Attempted synthesis of 4.40b. 
In order to add another urea moiety into 4.38c directly the two hydroxyl groups on it need to be 
activated in order to do a Ritter-type reaction. Specifically speaking, the tosylated bis-urea 4.41a 




Unfortunately, all attempts to tosylate the free hydroxyl groups were unsuccessful and hence the 
Ritter-type reaction could not be carried out.125, 126 (Scheme 4.14) 
 
Scheme 4.14: Attempted synthesis of tetra-urea 4.41b. 
As a last resort we submitted 4.38c to Appel reaction conditions. We added the bis-urea 4.38c to 
a solution of carbon tetrachloride and DMF followed by the addition of triphenyl phosphine and 
sodium azide under inert conditions and left the reaction mixture to stir overnight.127 Sadly, an 
unknown mixture of compounds was obtained which was discarded. (Scheme 4.15) 
 
Scheme 4.15: Attempted synthesis of 4.40b. 
We also tried to make an iodoarene possessing chiral urea and amide arms. In order to achieve 
this, we took 4.38f and refluxed it in thionyl chloride for two hours.115 After such time, we treated 





Scheme 4.16: Attempted synthesis of chiral iodoarene having urea and amide arms. 
4.2.3. Synthesis of C2-symmetric iodoarenes bearing chiral urea-carbamate arm 
Next we synthesised another class of C2-symmetric iodoarenes containing urea-carbamate 
functionalities on the chiral arm. We coupled commercially available isocyanate 4.44 with (S)-2-
amino-3-phenylpropan-1-ol 4.26 in dry THF using aforementioned procedure and obtained 4.45 
quantitatively. 118 Subsequently, we treated it with 4.18 in the presence of triethylamine in 
dichloromethane and left it to stir for 18 hours. Gratifyingly, iodoarene 4.46 was obtained in 65% 
yield. (Scheme 4.17) 
 






4.2.4. Synthesis of C2-symmetric iodoarenes bearing chiral amide arm 
Iodoarenes bearing an amide arm had been previously synthesised and tested in enantioselective 
α-oxidation of ketones in our group.128 So it would be worthwhile to prepare this kind of catalyst 
and to explore their reactivity in enantioselective spirocyclisation reactions. We refluxed 2-
iodoisophthalic acid 4.17 in SOCl2 for two hours and then coupled it with the hydrochloride salt 
of methyl-L-leucinate 4.35a and ethyl L-phenylalaninate 4.35b to obtain the desired bis-amide 
4.47a-b in 40% and 67% yields respectively. 
 
 







4.2.5. Synthesis of C2-symmetric λ3-iodanes 
We envisaged that it would be advantageous to convert a few novel iodoarenes to λ3-iodanes to 
evaluate them later in the enantioselective spirocyclisation reactions. For this purpose, we chose 
iodoarene 4.38c as a model substrate and subjected it to two different conditions that would 
generate I(III) species.129, 130 Unfortunately, analysis showed the decomposition of the starting 
iodoarene therefore the corresponding iodoarene(III) could not be obtained. (Scheme 4.19) 
 
 Scheme 4.19: Attempted synthesis of C2-symmetric iodane(III). 
4.2.6. Enantioselective oxidative cyclisation of naphthol amides 
Having synthesised novel C1 and C2-symmetric iodoarenes containing chiral urea, chiral 
carbamate, chiral amide and chiral urea-carbamate arms we decided to explore their oxidising 
potential in the enantioselective naphthol amide spirocyclisation. At the beginning, most of the 
reactions were carried out in polar aprotic solvents like acetonitrile or acetonitrile in combination 
with alcoholic solvents however extremely poor enantioselectivities or no enantioselectivities were 
obtained. 
 






Table 9: Optimisation of the dearomatisation reaction conditions. 
a 
Crude yields were determined by adding 1,3,5-Trimethoxybenzene as internal standard 
b 
Isolated yields after 
column chromatography. 
c 
Enantiomeric excess were determined by using chiralpak IB column (Petroleum 
ether:Isopropanol 80:20). 
d 
Pure sample could not be obtained. N.R. = No reaction. N.D. No development
 

































































Based upon the obtained results, we concluded that the solvents that performed the best in the 
racemic series were completely unsuitable for the enantioselective reaction (table 9, entries 1-6 
and 8-10). Substituting solvent to ethyl acetate lead to diminished yield while the addition of 
ethanol as additive along with acetonitrile increased the rate of reaction but at the cost of 
enantioselectivity. (table 9, entries 7, 11).  
Next, we subjected amide 3.33a to dearomatisation conditions in the presence of C1 and C2-
symmetric urea based iodoarenes. The results of our investigation are summarised below. (table 
10). 
 
Scheme 4.21: Enantioselective dearomatisation of naphthol amide 3.33a mediated by different C1 
and C2-symmetric iodoarenes.







20 mol% MeCN 
– 20 oC (4hr) 
then RT 
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Crude yields were determined by adding 1,3,5-Trimethoxybenzene as internal standard. 
b 
Pure sample could not be 
obtained. N.R. = No reaction. N.D. No development
 
Table 10: Optimisation of the dearomatisation reaction conditions. 
Lowering the temperature to -20 °C had a disfavourable effect upon the reaction as it led to lower 
yields (table 10, entries 1-3). The use of iodoarenes 4.36 and 4.34 also provided poorer yields 
(table 10, entries 4-5). Trying oxidants other than mCPBA failed to produce the desired product 
and led to complex reaction mixtures (table 10, entries 6-7). 
Ishihara et al.92 showed that the addition of alcoholic solvents like HFIP or MeOH to the reaction 
mixture improved the yield and the ee of products of oxidative ortho-lactonisation. Accordingly, 
we decided to carry out further experiments employing similar modifications. 
 















Crude yields were determined by adding 1,3,5-Trimethoxybenzene as internal standard 
b 
Isolated yields after 
column chromatography. 
c 
Enantiomeric excess were determined by using chiralpak IB column (Petroleum 
ether:Isopropanol 80:20). N.R. = No reaction. N.D. No development 
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Table 11: Optimisation of the dearomatisation reaction conditions of amide 3.33a, b. 
It was noted the rate of reaction was slightly faster when anhydrous methanol was added as additive 
along with dichloromethane however it failed to improve the enantioselectivities (table 11, entries 
3-6, 11-12). In some other cases, the use of dichloromethane and methanol were not found to be 
useful as it led to lower yields (table 11, entries 7-8). It was also observed that the reaction did not 
proceed as expected upon using iodoarene 4.47, 4.40 and 4.38e. Our analysis of the crude mixture 
showed the presence of unreacted starting material in all these cases (table 11, entries 2, 8-10). 
4.2.7. Summary 
New chiral C1 and C2-symmetric iodoarenes were successfully designed and evaluated in oxidative 
spirocyclisation of naphthol amides as an attempt to improve the overall yield of the reaction and 
enantioselectivity. Yet, it remains rather elusive to attain high enantioselectivities and high yields 
simultaneously. As a matter of fact, the solvents which gave augmented yields resulted in the 
formation of racemic product whilst the solvents which promote asymmetric induction afforded 
low yields. The future work will be the continuation of our investigation into developing 
enantioselective conditions for the cyclisation of naphthol amides by designing and evaluating new 
chiral iodoarenes.         




4.2.8. Future work 
We have described hypervalent iodine(III) promoted dearomatisation of phenol and naphthol 
amides leading to the formation of a library of novel functionalised spirocycles. Although we have 
shown a wide reaction scope by altering the aryl/ alkyl substituent attached to the amide moiety to 
access more than 35 novel oxazoline based spirocycles however research into hypervalent 
iodine(III) mediated dearomatisation of phenols, naphthols and indoles remains under 
investigated.  
Moreover, the developed strategy for the dearomatisation of phenols and naphthols can be 
extended to the indoles to access complex oxazoline based spirocycles containing indole derived 
core. (Scheme 4.23).          
 
Scheme 4.23: Hypervalent iodine(III) mediated dearomatisation of indoles.  
Additionally, further investigation into enantioselective dearomatisation of naphthols remains a 
major challenge. For this purpose, new iodoarene precatalyst(s) containing optically active lactam 
moiety shall be synthesised and evaluated in order to get enantioenriched naphthol based 
spirocycles. (scheme 4.24). 
 








Chapter 5  Experimental 
Unless otherwise stated, proton (1H NMR, 300, 400 MHz) and carbon (13C NMR, 100, 75 MHz) 
spectra were recorded in deuterated chloroform (CDCl3) solution at room temperature. Chemical 
shifts are reported in parts per million (ppm) while the coupling constants, J, are in hertz (Hz). 
Multiplicities are provided as “s” (singlet), “d” (doublet), “t” (triplet), “q” (quartet), “p” (pentet), 
“dd” (doublet of doublets), “dt” (doublet of triplets), “ddd” (doublet of doublet of doublets), “m” 
(multiplet), “td” (triplet of doublets). Infrared (IR) spectra (cm–1) were recorded on Nicolet 380 
spectrum spotlight system, equipped with a diamond probe ATR attachment.  Low and high-
resolution mass spectra (m/z) were obtained in the electrospray (ESI) mode. Melting points 
(uncorrected) were measured on a Stuart SMP10 apparatus. 
All reagents and solvents were purchased from commercial sources and used without further 
purification except THF (freshly distilled from Na/benzophenone under argon). The reactions were 
monitored by thin layer chromatography (TLC) using silica gel 60 F254 pre-coated plates. Spots 
were visualized with a UV lamp, KMnO4 stain or vanillin stain. Flash chromatographic 
separations were performed on Aldrich, 35-70µ, 60A silica gel as per literature conditions. 
Enantiomeric excesses were determined with analytical chiral columns Chiralpak IA and 
Chiralpak IB with UV detector at 254 nm or 286.16nm. 
Synthesis of Benzamides 
General Procedure A  
To a solution of the amine (2.44 mmol, 1 equiv.) and base (1 equiv.) in DCM (12 mL) at 0 oC was 
added an acid chloride (1 equiv.) which was left to stir at room temperature for 1-2 hours. The 
reaction mixture was diluted with DCM (50 mL), quenched with NaHCO3 (25 mL) and the organic 
layer was separated and concentrated under vacuum. The obtained residue was diluted with MeOH 
(25 mL) and DCM (5 mL) and NaOH (1 M, 18 mL) was added. After stirring for 10 minutes at 
room temperature, TLC analysis showed any bis-acylated product was cleaved to give the desired 
mono-acylated product. The reaction mixture was acidified with glacial acetic acid until neutral 
and then concentrated under vacuum. The product was extracted with DCM (50 mL) and washed 




reduced pressure. Organic residues were purified by recrystallisation (MeOH/Petroleum) to give 
the desired product as a solid. (50-60% yield). 
General Procedure B 
A solution of acyl chloride (2 mmol) in THF (4 mL) was cooled to 0 oC under nitrogen. Potassium 
phosphate tribasic (2.5 mmol) was added in one portion followed by the amine (2 mmol). The 
mixture was stirred for 1-2 hour at room temperature then the reaction mixture was concentrated 
under reduced pressure. Water (6 mL) and EtOAc (2 mL) were added, the organic layer separated 
and then washed with 0.5 N HCl (5 mL) followed by water (5 mL). The organic layer was dried 
over MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by 
recrystallisation in EtOAc-Hexanes. 
General Procedure C 
Synthesis of Substituted Naphthol Amides 
To the appropriate naphthol or substituted naphthol (1.0 g, 6.94 mmol) and unsaturated 
hydrocarbon amide (1.05 g, 6.94 mmol) were dissolved in anhydrous ethanol (100 mL). 
Concentrated sulfuric acid (10 mL) was added dropwise and the reaction mixture was stirred for 7 
hours at 50 oC. After such time, the reaction mixture was cooled down and washed with 1 M NaOH 
(50 mL). The combined organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure. The residue was recrystallised from Hexane-Ethyl acetate to afford the desired 
product.  
Synthesis of N-(4-hydroxybenzyl)benzamide 3.1 
 
Procedure A was used to obtain N-(4-hydroxybenzyl)benzamide as colourless solid. Yield (1.03 
g, 55%).  




1H NMR: (DMSO-d6, 400 MHz) δ: 9.31 (br, s, 1H), 8.96 (br, s, 1H), 7.90 (d, J = 7.1 Hz, 2H), 7.54-
7.44 (m, 3H), 7.14 (d, J = 8.4 Hz, 2H), 6.73 (d, J = 8.4 Hz, 2H), 4.38 (d, J = 6.0 Hz, 2H).   
13C NMR: (DMSO-d6, 75 MHz) δ: 166.5, 156.7, 134.9, 131.6, 130.3, 129.0, 128.7, 127.7, 115.4, 
42.6.  
HRMS: m/z calc’d for C14H13NO2 [M+Na]
 + 250.0838, found 250.0840. 
Melting Point: 151-153 ℃. 
Synthesis of 4-chloro-N-(4-hydroxybenzyl)benzamide 3.2 
 
Compound was prepared using general procedures A as off-white solid (Yield 1.03 g, 49%). 
FT-IR (cm-1): ν = 3353, 3176, 2921, 1630.      
1H NMR: (DMSO-d6, 400 MHz) δ: 9.29 (s, 1H), 9.02 (br, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.54 (d, J 
= 8.6 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H), 6.71 (d, J = 8.5 Hz, 2H), 4.35 (d, J = 6.0 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 165.3, 156.7, 136.4, 133.6, 130.1, 129.6, 129.1, 128.8, 115.4, 
42.7. 
HRMS: m/z calc’d for C14H12ClNO2 [M+H]
 + 262.0629, found 262.0631.  
Melting Point: Literature M.P.131: 196-197 ℃, Experimental M.P. 195-196 ℃. 
Synthesis of N-(4-hydroxybenzyl)-4-methoxybenzamide 3.3 
 




FT-IR (cm-1): ν = 3257, 3009, 2971, 2936, 2836, 1604.   
1H NMR: (DMSO-d6, 400 MHz) δ: 9.26 (s, 1H), 8.78 (br, 1H), 7.86 (d, J = 8.9 Hz, 2H), 7.11 (d, J 
= 8.5 Hz, 2H), 6.99 (d, J = 8.9 Hz, 2H), 6.70 (d, J = 8.5 Hz, 2H), 4.34 (d, J = 6.0 Hz, 2H), 3.80 (s, 
3H).   
13C NMR: (DMSO-d6, 75 MHz) δ: 165.9, 161.9, 156.6, 131.8, 130.5, 129.5, 127.1, 115.4, 113.9, 
55.8, 42.5. 
HRMS: m/z calc’d for C15H15NO3 [M+H]
 + 258.1125, found 258.1126.  
Melting Point: 155-156 ℃.  
Synthesis of N-(4-hydroxybenzyl)-4-methylbenzamide 3.4 
 
Compound was obtained as light yellow crystalline solid through general method A (Yield 0.35 g, 
59%).  
FT-IR (cm-1): ν = 3017, 2922, 1628, 1508, 1237, 745.  
1H NMR: (CDCl3, 400 MHz) δ: 7.67 (d, J = 8.1 Hz, 2H), 7.23-7.19 (m, 4H), 6.80 (d, J = 8.3 Hz, 
2H), 6.33 (t, J = 5.7 Hz, 1H), 5.57 (s, 1H), 4.35 (d, J = 5.7 Hz, 2H), 2.38 (s, 3H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 167.5, 155.5, 142.1, 131.4, 130.0, 129.4, 129.3, 127.0, 115.7, 
43.7, 21.5. 
HRMS: m/z calc’d for C15H15NO2 [M+H]
 + 242.1176, found 242.1180.  









Synthesis of N-(4-hydroxybenzyl)-2,4,6-trimethylbenzamide 3.5 
 
Compound was prepared by general method B as pale yellow solid (Yield 0.81 g, 46%). 
FT-IR (cm-1): ν = 3373, 3163, 2917, 1620.    
1H NMR: (DMSO-d6, 400 MHz) δ: 9.29 (s, 1H), 8.61 (br, 1H), 7.14 (d, J = 8.5 Hz, 2H), 6.83 (s, 
2H), 6.71 (m, 2H), 4.30 (d, J = 6.0 Hz, 2H), 2.23 (s, 3H), 2.13 (s, 6H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 169.5, 156.7, 137.5, 136.3, 134.0, 130.0, 129.3, 128.0, 115.4, 
42.2, 21.1, 19.3. 
HRMS: m/z calc’d for C17H19NO2 [M+H]
 + 270.1489, found 270.1496.  
Melting Point: 150-151 ℃.  
Synthesis of N-(4-hydroxybenzyl)-3,5-dimethylbenzamide 3.6 
 
Compound was prepared by general method B as beige colour solid (Yield 3.4 g, 63%). 
FT-IR (cm-1): ν = 3260, 2914, 1621, 1515.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.28 (s, 1H), 8.83 (t, J = 5.9 Hz, 1H), 7.50 (s, 2H), 7.14 (s, 1H), 
7.12 (d, J = 8.4 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 4.34 (d, J = 5.9 Hz, 2H), 2.31 (s, 6H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 166.7, 156.7, 138.0, 135.0, 132.8, 130.4, 129.1, 125.8, 115.4, 
42.6, 21.3.  
HRMS: m/z calc’d for C16H17NO2 [M+H]




Melting Point: 165-166 ℃. 
Synthesis of 2,3-dichloro-N-(4-hydroxybenzyl)benzamide 3.7 
 
Compound was prepared by general method B as white solid (Yield 1.3 g, 68%). 
FT-IR (cm-1): ν = 3331, 3066, 1624, 772.   
1H NMR: (DMSO-d6, 400 MHz) δ: 9.33 (s, 1H), 8.96 (t, J = 5.6 Hz, 1H), 7.70 (d, J = 7.3 Hz, 1H), 
7.42-7.34 (m, 2H), 7.16 (d, J = 8.2 Hz, 2H), 6.74 (d, J = 8.2 Hz, 2H), 4.34 (d, J = 5.8 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 166.0, 156.8, 139.9, 132.5, 131.4, 129.5, 129.1, 128.9, 128.6, 
127.8, 115.5, 42.5.   
HRMS: m/z calc’d for C14H11Cl2NO2 [M+H]
 + 296.0240, found 296.0250.  
Melting Point: 161-163 ℃. 
Synthesis of 2,5-dibromo-N-(4-hydroxybenzyl)benzamide 3.8 
 
Compound was prepared by general method B as dark brown solid (Yield 1.93 g, 34%). 
FT-IR (cm-1): ν = 3290, 3076, 1628, 1580, 1510, 1310, 1225.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.32 (s, 1H), 8.94 (t, J = 5.7 Hz, 1H), 7.62-7.54 (m, 3H), 7.20 
(d, J = 8.3 Hz, 2H), 6.73 (d, J = 8.3 Hz, 2H), 4.32 (d, J = 5.8 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 166.1, 156.9, 141.4, 135.2, 134.0, 131.7, 129.4, 129.2, 121.0, 




HRMS: m/z calc’d for C14H11Br2NO2 [M+H]
+ 383.9229, found 385.9231.   
Melting Point: 187-188 ℃. 
Synthesis of  N-(4-hydroxybenzyl)-3-nitrobenzamide 3.9 
 
Compound was prepared by general method A as beige powder (Yield 2 g, 45%).  
FT-IR (cm-1): ν = 3080, 3022, 1634, 1530, 1344, 1223.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.50 (s, 1H), 9.35 (t, J = 5.7 Hz, 1H), 8.72 (t, J = 1.7 Hz, 1H), 
8.39-8.32 (m, 2H), 7.77 (t, J = 8.1 Hz, 1H), 7.15 (d, J = 8.4 Hz, 2H), 6.73 (d, J = 8.4 Hz, 2H), 4.40 
(d, J = 5.7 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 164.3, 157.0, 148.3, 136.3, 134.2, 130.6, 129.7, 129.3, 126.3, 
122.5, 115.5, 43.0.  
HRMS: m/z calc’d for C14H12N2O4 [M+H]
+ 273.0870, found 273.0874. 
Melting Point: 168-169 ℃. 
Synthesis of N-(4-hydroxybenzyl)-3,5-dinitrobenzamide 3.10 
 
Compound was prepared by general method B as yellow solid (Yield 2.1 g, 45%). 
FT-IR (cm-1): ν = 3435, 3107, 1644, 1530, 1350.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.64 (t, J = 9.3 Hz, 1H), 9.35 (s, 1H), 9.10 (d, J = 1.8 Hz, 2H), 





13C NMR: (DMSO-d6, 75 MHz) δ: 162.3, 157.0, 148.7, 137.4, 129.5, 129.3, 128.1, 121.3, 115.6, 
43.3.   
HRMS: m/z calc’d for C14H11N3O6 [M+H]
 + 318.0721, found 318.0717.  
Melting Point: 204-205 ℃. 
Synthesis of N-(4-hydroxybenzyl)-2-phenylacetamide 3.11 
 
Compound was obtained as white solid through general method B (0.91g, 46%). 
FT-IR (cm-1): ν = 3218, 3060, 1612, 1588, 1482. 
1H NMR: (DMSO-d6, 400 MHz) δ: 9.29 (s, 1H), 8.43 (br, 1H), 7.32-7.22 (m, 5H), 7.03 (d, 
J= 8.5 Hz, 2H), 6.69 (d, J= 8.5 Hz, 2H), 4.41 (d, J= 6.0 Hz, 2H), 3.44 (s, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 170.3, 156.7, 136.9, 130.0, 129.4, 129.0, 128.6, 126.7, 115.4, 
42.8, 42.3. 
HRMS: m/z calc’d for C15H15NO2 [M+H]
 + 241.1103, found 241.1110.  
Melting Point: 173-175 ℃. 
Synthesis of 2-fluoro-N-(4-hydroxybenzyl)benzamide 3.12 
 
Compound was prepared by general method B as beige coloured solid (Yield 1.40 g, 54%). 




1H NMR: (DMSO-d6, 400 MHz) δ: 9.30 (s, 1H), 8.74 (t, J = 6.0 Hz, 1H), 7.63-7.57 (m, 1H), 7.52-
7.47 (m, 1H), 7.30-7.24 (m, 2H), 7.13 (d, J = 8.4 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 4.33 (d, J = 
5.9 Hz, 2H) 
13C NMR: (DMSO-d6, 75 MHz) δ: 164.0, 159.6 (d, J = 248.6 Hz), 156.7, 132.7 (d, J = 8.4 Hz), 
130.5 (d, J = 3.3 Hz), 129.8, 128.9, 124.9 (d, J = 3.3 Hz), 124.7 (d, J = 14.6 Hz), 116.5 (d, J = 22.3 
Hz), 115.5, 42.6.  
HRMS: m/z calc’d for C14H12FNO2 [M+H]
 + 246.0925, found 246.0928.  
Melting Point: 129-130 ℃. 
Synthesis of N-(4-hydroxybenzyl)-4-(trifluoromethyl)benzamide 3.13 
 
Compound was prepared by general method A as white solid (Yield 1.5 g, 78%). 
FT-IR (cm-1): ν = 3355, 3193, 1635, 1190.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.30 (s, 1H), 9.18 (t, J = 5.6 Hz, 1H), 8.07 (d, J = 8.1 Hz, 2H), 
7.85 (d, J = 8.2 Hz, 2H), 7.14-7.12 (m, 2H), 6.73-6.70 (m, 2H), 4.38 (d, J = 5.7 Hz, 2H).   
13C NMR: (DMSO-d6, 75 MHz) δ: 165.2, 156.7, 138.6, 131.7, 131.3, 129.9, 129.1, 128.6, 125.8 (q, 
J = 272 Hz), 115.5, 42.8. 
HRMS: m/z calc’d for C15H12F3NO2 [M+H]
 + 296.0893, found 296.0896.  








Synthesis of N-(4-hydroxybenzyl)-3-(trifluoromethyl)benzamide 3.14 
 
Compound was prepared by general method A as light pink solid (Yield 1.2 g, 63%). 
FT-IR (cm-1): ν = 3307, 3139, 1632, 1441.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.34 (s, 1H), 9.21 (t, J = 5.7 Hz, 1H), 8.23 (s, 1H), 8.19 (d, J = 
7.8 Hz, 1H), 7.90 (d, J = 7.8 Hz, 1H), 7.72 (t, J = 7.8 Hz, 1H), 7.14 (d,  J= 8.4 Hz, 2H), 6.72 (d, J 
= 8.4 Hz, 2H), 4.39 (d, J = 5.8 Hz, 2H),      
13C NMR: (DMSO-d6, 75 MHz) δ: 165.01, 156.8, 135.7, 131.8, 130.1, 129.8, 129.7, 129.4, 129.2, 
128.2 (q, J = 32.0 Hz), 124.2 (q, J = 272.2 Hz), 115.5, 42.8.    
HRMS: m/z calc’d for C15H12F3NO2 [M+H]
 + 296.0893, found 296.0898.  
Melting Point: 154-155 ℃. 
Synthesis of N-(4-hydroxybenzyl)-3,5-bis(trifluoromethyl)benzamide 3.15 
 
Compound was prepared by general method A as pink solid (Yield 2.4 g, 68%). 
FT-IR (cm-1): ν = 3272, 3140, 1642, 1286, 1142.   
1H NMR: (DMSO-d6, 400 MHz) δ: 9.42 (t, J = 5.6 Hz, 1H), 9.34 (s, 1H), 8.54 (s, 2H), 8.31 (s, 1H), 
7.16 (d, J = 8.4 Hz, 2H), 6.73 (d, J = 8.4 Hz, 2H), 4.42 (d, J = 5.7 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 163.4, 156.9, 137.0, 131.0 (q, J = 33.1 Hz), 129.5, 129.4, 128.6 




HRMS: m/z calc’d for C16H11F6NO2 [M+H]
 + 364.0772, found 364.0770.  
Melting Point: 176-177 ℃. 
Synthesis of 3-fluoro-N-(4-hydroxybenzyl)-4-methylbenzamide 3.16 
 
Compound was prepared by general method B as pink solid (Yield 1.78 g, 53%). 
FT-IR (cm-1): ν = 3314, 3012, 1630.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.30 (s, 1H), 8.96 (t, J = 5.8 Hz, 1H), 7.64 (m, 2H), 7.38 (t, J = 
8.0 Hz, 1H), 7.12 (d, J = 8.4 Hz, 2H), 6.71 (d, J= 8.4 Hz, 2H), 4.40 (d, J = 5.9 Hz, 2H), 2.30 (s, 
3H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 165.1 (d, J = 2.3 Hz), 162.0, 159.6, 156.7, 134.6 (d, J = 7.0 Hz), 
132.0 (d, J = 5.1 Hz), 130.1, 129.1, 128.2 (d, J = 17.5 Hz), 123.5 (d, J = 3.4 Hz), 115.5, 114.1 (d, 
J = 23.6 Hz), 42.7, 14.6 (d, J = 3.3 Hz).  
HRMS: m/z calc’d for C15H14FNO2 [M+H]
 + 260.1081, found 260.1086.  
Melting Point: 131-132 ℃. 
Synthesis of N-(4-hydroxybenzyl)furan-2-carboxamide 3.17 
 
Compound was prepared by general method B as pink solid (Yield 1.15 g, 65%). 
FT-IR (cm-1): ν = 3119, 2815, 1633, 1591, 1513, 1221, 1184, 1038.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.29 (s, 1H), 8.81 (t, J = 6.0 Hz, 1H), 7.83 (s, 1H), 7.12-7.10 (m, 




13C NMR: (DMSO-d6, 75MHz) δ: 158.1, 156.7, 148.4, 145.4, 130.1, 129.1, 115.4, 113.8, 112.3, 
41.9.  
HRMS: m/z calc’d for C12H11NO3 [M+H]
+ 218.0812, found 218.0815.  
Melting Point: 162-163 ℃. 
Synthesis of N-(4-hydroxybenzyl)-1H-pyrrole-2-carboxamide 3.18 
 
Compound was prepared by general method B as brick red powder (Yield 1.37, 39%). 
FT-IR (cm-1): ν = 3417, 3115, 2838, 1650, 1526, 1513, 1334, 1188.   
1H NMR: (DMSO-d6, 400 MHz) δ: 11.44 (s, 1H), 9.30 (s, 1H), 8.41 (t, J = 6.0 Hz, 1H), 7.10 (d, J = 
8.4 Hz, 2H), 6.86-6.84 (m, 1H), 6.81-6.80 (m, 1H), 6.71 (d, J = 8.4 Hz, 2H), 6.10-6.06 (m, 1H), 
4.31 (d, J = 6.0 Hz, 2H). 
13C NMR: (DMSO-d6, 75MHz) δ: 161.0, 156.6, 130.7, 129.0, 126.8, 121.7, 115.4, 110.3, 109.0, 
41.8.  
HRMS: m/z calc’d for C12H12N2O2 [M+H]
+ 217.0972, found 217.0976.  
Melting Point: 175-176 ℃. 
Synthesis of N-(4-hydroxybenzyl)-1H-indole-2-carboxamide 3.19 
 
Compound was prepared by general method A as red solid (Yield 1.37, 39%). 




1H NMR: (DMSO-d6, 400 MHz) δ: 11.60 (s, 1H), 9.31 (s, 1H), 8.92 (t, J = 6.0 Hz, 1H), 7.60 (d, J = 
8.0 Hz, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.19-7.14 (m, 4H), 7.05-7.01 (m, 1H), 6.73 (d, J = 8.4 Hz, 
2H), 4.40 (d, J = 6.0 Hz, 2H). 
13C NMR: (DMSO-d6, 75MHz) δ: 161.4, 156.7, 136.9, 132.2, 130.2, 129.1, 127.6, 123.7, 122.0, 
120.1, 115.5, 112.8, 103.0, 42.2.  
HRMS: m/z calc’d for C16H15N2O2
+ [M+H]+ 267.1128, found 267.1129.  
Melting Point: 175-176 ℃. 
Synthesis of N-(4-hydroxybenzyl)thiophene-2-carboxamide 3.20 
 
Compound was prepared by general method B as light brown solid (Yield 0.97 g, 51%). 
FT-IR (cm-1): ν = 3073, 2827, 1613, 1548, 1510, 1239.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.29 (s,1H), 8.93 (t, J = 5.8 Hz, 1H), 7.80 (d, J = 3.7 Hz, 1H), 
7.74 (d, J = 5.0 Hz, 1H), 7.13 (m, 3H), 6.72 (d, J = 8.4 Hz, 2H), 4.34 (d, J = 6.0 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 161.4, 156.8, 140.6, 131.2, 130.1, 129.1, 128.4, 128.3, 115.6, 
42.7.   
HRMS: m/z calc’d for C12H11NO2S [M+H]
+ 234.0583, found 234.0587.  
Melting Point: 191-192 ℃.  





Compound was prepared by general method B as light brown crystalline solid (Yield 0.2 g, 78%). 
FT-IR (cm-1): ν = 3242, 3062, 2357, 1606, 1519, 1268, 1239. 
1H NMR: (DMSO-d6, 400 MHz) δ: 9.34 (s, 1H), 8.90 (t, J = 5.8 Hz, 1H), 8.12 (m, 1H), 7.90 (m, 
1H), 7.60 (m, 2H), 7.20 (d, J = 8.3 Hz, 2H), 6.74 (d, J = 8.3 Hz, 2H), 4.41 (d, J = 5.9 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 160.7, 156.9, 137.1, 136.5, 132.9, 129.5, 129.2, 128.0, 126.4, 
124.0, 123.0, 119.2, 115.6, 43.1.  
HRMS: m/z calc’d for C16H12ClNO2S [M+H]
+ 318.0350, found 318.0350.  
Melting Point: 200-201 ℃. 
Synthesis of N-(4-hydroxybenzyl)picolinamide 3.22 
 
Compound was prepared by general method B as brown solid (Yield 1.16 g, 61%). 
FT-IR (cm-1): ν = 3175, 2850, 1632, 1531, 1514, 1231.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.30 (s, 1H), 9.18 (t, J = 5.8 Hz, 1H), 8.62-8.61 (m, 1H), 8.05-
7.95 (m, 2H), 7.59-7.56 (m, 1H), 7.15 (d, J = 8.2 Hz, 2H), 6.70 (d, J = 8.2 Hz, 2H), 4.40 (d, J = 
6.2 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 164.2, 156.8, 150.6, 148.9, 138.2, 130.2, 129.3, 126.9, 122.4, 
115.5, 42.5.   
HRMS: m/z calc’d for m/z calc’d for C13H12N2O2 [M+H]
+ 229.0972, found 229.0975. 







Synthesis of N-(4-hydroxybenzyl)nicotinamide 3.23 
 
Compound was prepared by general method B as pale yellow solid (Yield 0.96 g, 47%). 
FT-IR (cm-1): ν = 3173, 2847, 1638, 1542, 1525, 1236.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.31 (s, 1H), 9.14 (t, J = 5.6 Hz, 1H), 9.04 ( d, J = 1.7 Hz, 1H), 
8.71-8.69 (m, 1H), 8.21 (d, J = 7.9 Hz, 1H), 7.51 (dd, J1 = 7.9, J2 = 4.8 Hz, 1H), 7.14 (d, J = 8.3 
Hz, 2H), 6.72 (d, J = 8.3 Hz, 2H), 4.40 (d, J = 5.9 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 165.1, 156.8, 152.3, 148.9, 135.5, 130.4, 129.9, 129.1, 123.9, 
122.4, 115.5, 42.5.   
HRMS: m/z calc’d for m/z calc’d for C13H12N2O2 [M+H]
+ 229.0972, found 229.0980. 
Melting Point: 183-186 ℃. 
Synthesis of N-(4-hydroxybenzyl)acetamide 3.24 
 
Compound was prepared by general method A as pale yellow sticky solid (Yield 0.28 g, 42%). 
FT-IR (cm-1): ν = 3017, 2812, 2690, 1626, 1593, 1514, 1222.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.28 (s, 1H), 8.21 (t, J = 5.8 Hz, 1H), 7.04 (d, J = 8.3 Hz, 2H), 
6.70 (d, J = 8.3 Hz, 2H), 4.11 (d, J = 5.8 Hz, 2H), 1.84 (s, 3H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 169.4, 156.7, 130.2, 129.1, 115.5, 42.4, 23.2.  
HRMS: m/z calc’d for C9H11NO2 [M+H]




Melting Point: 116-117 ℃. 
Synthesis of N-(4-hydroxybenzyl)pivalamide 3.25 
 
Compound was prepared by general method B as brown solid (0.8 g, 48%).  
FT-IR (cm-1): ν = 3418, 3121, 2963, 2932, 1627.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.23 (s, 1H), 7.92 (br, 1H), 7.00 (d, J = 8.5 Hz, 2H), 6.68 (d, J 
= 8.5 Hz, 2H), 4.14 (d, J = 6.0 Hz, 2H), 1.11 (s, 9H).     
13C NMR: (DMSO-d6, 75 MHz) δ: 177.6, 156.5, 130.8, 128.5, 115.3, 42.0, 38.4, 27.9. 
HRMS: m/z calc’d for C12H17NO2 [M+H]
+ 208.1332, found 208.1337.  
Melting Point: 135-136 ℃. 
Synthesis of 2,2,2-trichloro-N-(4-hydroxybenzyl)acetamide 3.26 
 
Compound was prepared by general method B as pale yellow sticky solid (Yield 0.31 g, 49%). 
FT-IR (cm-1): ν = 3250, 3061, 2850, 1631, 1556, 1385, 1254.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.28 (s, 1H), 8.21 (t, J = 5.8 Hz, 1H), 7.04 (d, J = 8.3 Hz, 2H), 
6.70 (d, J = 8.3 Hz, 2H), 4.11 (d, J = 5.8 Hz, 2H), 1.84 (s, 3H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 169.4, 156.7, 130.2, 129.1, 115.5, 42.4, 23.2.  
HRMS: m/z calc’d for C9H9Cl3NO2
+ [M+H]+ 267.9693, found 267.9698.  




Synthesis of N-(4-hydroxybenzyl)cyclopropanecarboxamide 3.27 
 
Compound was prepared by general method B as pink solid (Yield 0.21 g, 30%). 
FT-IR (cm-1): ν = 3280, 3181, 2954, 1634, 1599, 1575, 1385, 1246. 
1H NMR: (DMSO-d6, 400 MHz) δ: 9.29 (s, 1H), 8.42 (t, J = 5.5 Hz, 1H), 7.05 (d, J = 7.9 Hz, 2H), 
6.70 (d, J = 7.9 Hz, 2H), 4.15 (d, J = 6.0 Hz, 2H), 1.60-1.55 (m, 1H), 0.71-0.61 (m, 4H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 172.8, 156.7, 130.2, 129.1, 115.4, 42.3, 14.0, 6.6.  
HRMS: m/z calc’d for C11H14NO2 [M+H]
+ 192.1019, found 192.1022.  
Melting Point: 115-118 ℃. 
Synthesis of N-(4-hydroxybenzyl)cyclohexanecarboxamide 3.29 
 
Compound was prepared by general method B as beige coloured solid (Yield 0.53 g, 61%). 
FT-IR (cm-1): ν = 3277, 2929, 2853, 1625, 1592, 1541, 1515, 1366, 1207, 1169. 
1H NMR: (DMSO-d6, 400 MHz) δ: 9.24 (s, 1H), 8.07 (t, J = 5.8 Hz, 1H), 7.00 (d, J = 8.3 Hz, 2H), 
6.67 (d, J = 8.3 Hz, 2H), 4.10 (d, J = 5.9 Hz, 2H), 2.15-2.07 (m, 1H), 1.69-1.58 (m, 5H), 1.37-1.1 
(m, 6H).   
13C NMR: (DMSO-d6, 75 MHz) δ: 175.4, 156.6, 130.4, 128.7, 115.4, 44.5, 41.8, 29.7, 26.0, 25.7.   
HRMS: m/z calc’d for C14H20NO2 [M+H]
+ 234.1489, found 234.1488.  





Synthesis of N-(4-hydroxybenzyl)formamide 3.30 
 
Compound was prepared by using known literature procedure as yellow solid.132 (Yield 2.3 g, 
95%). 
FT-IR (cm-1): ν = 3254, 3023, 2889, 2818, 2692, 1651, 1597, 1537, 1512, 1455, 1381, 1330, 1245, 
1172, 1085, 828.  
1H NMR: (CDCl3, 300 MHz) δ: 8.30 (s, 1H), 7.18 (d, J = 8.5 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 5.80 
(s, 1H), 5.10 (s, 1H), 4.43 (d, J = 5.8 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 161.3, 156.7, 129.5, 129.1, 115.5, 40.7.  
HRMS: m/z calc’d for C8H10NO2 [M+H]
+ 152.0706, found 152.0710.  
Melting Point: Literature M.P.132 124-126 °C, Experimental M.P. 121-123 °C.  
Synthesis of N-((2-hydroxynaphthalen-1-yl)methyl)benzamide 3.33a 
 
Compound was prepared by general method C as light brown solid (Yield 2.74 g, 71%). 
FT-IR (cm-1): ν = 3265, 3130, 1660, 1650.  
1H NMR: (DMSO-d6, 400 MHz) δ: 10.29 (s, 1H), 9.12 (t, J = 5.1 Hz, 1H), 8.10 (d, J = 8.5 Hz, 1H), 
7.91-7.89 (m, 2H), 7.82-7.77 (m, 2H), 7.47 (m, 4H), 7.31 (t, J = 7.4 Hz, 1H), 7.21 (d, J = 8.9 Hz, 




13C NMR: (DMSO-d6, 75 MHz) δ: 168.0, 154.4, 134.1, 133.8, 131.9, 129.8, 128.7, 127.9, 126.9, 
123.3, 123.1, 119.4, 116.1, 34.9.  
HRMS: m/z calc’d for C18H15NO2 [M+H]
+ 278.1176, found 278.1181. 
Melting Point: 177-178 ℃. 
Synthesis of N-((6-bromo-2-hydroxynaphthalen-1-yl)methyl)benzamide 3.33b 
 
Compound was prepared by general method C as pale yellow solid (Yield 0.95 g, 59%). 
FT-IR (cm-1): ν = 3462, 3425, 3148, 1624, 1572, 1501, 1293.  
1H NMR: (DMSO-d6, 400 MHz) δ: 10.40 (s, 1H), 9.07 (t, J = 5.1 Hz, 1H), 8.09 (d, J = 2.1 Hz, 1H), 
8.03 (d, J = 9.1 Hz, 1H), 7.88-7.86 (m, 2H), 7.78 (d, J = 8.9 Hz, 1H), 7.59 (dd, J1= 9.1 Hz, J2 = 2.2 
Hz, 1H), 7.54-7.52 (m, 1H), 7.46-7.42 (m, 2H), 7.25 (d, J = 9.0 Hz, 1H), 4.84 (d, J = 5.2 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 167.8, 154.8, 134.1, 132.5, 131.9, 130.4, 130.0, 129.7, 129.0, 
128.7, 127.9, 125.8, 120.5, 116.5, 115.9, 34.7.   
HRMS: m/z calc’d for C18H14BrNO2 [M+H]
+ 356.0281, found 356.0282.   
Melting Point: 211-212 ℃. 
Synthesis of N-((2-hydroxynaphthalen-1-yl)methyl)acetamide 3.33c 
 




FT-IR (cm-1): ν = 3243, 3097, 2357, 2340, 1622, 1555, 1225.  
1H NMR: (DMSO-d6, 400 MHz) δ: 10.16 (s, 1H), 8.46 (t, J = 5.0 Hz, 1H), 7.93 (d, J = 8.5 Hz, 1H), 
7.81 (d, J = 8.1 Hz, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.50-7.45 (m, 1H), 7.31 (t, J = 7.4 Hz, 1H), 7.17 
(d, J = 8.8 Hz, 1H), 4.62 (d, J = 5.4 Hz, 2H), 1.84 (s, 3H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 170.7, 154.2, 133.7, 129.7, 128.7, 128.6, 127.0, 123.2, 123.1, 
119.3, 116.3, 34.0, 22.7.  
HRMS: m/z calc’d for C13H13NO2 [M+H]
+ 216.1019, found 216.1022.  
Melting Point: 163-164 ℃. 
Synthesis of N-((6-bromo-2-hydroxynaphthalen-1-yl)methyl)acetamide 3.33d 
 
Compound was prepared by general method C as pale yellow solid (Yield 1.67 g, 63%). 
FT-IR (cm-1): ν = 3316, 3163, 1620, 1551, 1255, 1158, 1075.   
1H NMR: (DMSO-d6, 400 MHz) δ: 10.32 (s, 1H), 8.42 (t, J = 5.0 Hz, 1H), 8.10 (d, J = 2.1 Hz, 1H), 
7.90 (d, J = 9.1 Hz, 1H), 7.78 (d, J = 8.9 Hz, 1H), 7.55 (dd, J1 = 9.1 Hz, J2 = 2.1 Hz, 1H), 7.22 (d, 
J = 8.9 Hz, 1H), 4.60 (d, J = 5.4 Hz, 2H), 1.81 (s, 3H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 170.9, 154.7, 132.3, 130.4, 129.9, 129.7, 128.9, 125.7, 120.4, 
116.7, 115.4, 34.0, 22.7.  
HRMS: m/z calc’d for C13H12BrNO2 [M+H]
+ 294.0124, found 294.0128.  






Synthesis of Spirocycles  
General Procedure D for Cyclisation of Benzamide and Naphthol Amide Analogues 
To a stirred solution of amide (1 equiv.) in solvent (6 mL) was added m-CPBA (2.2 equiv.) and 4-
iodotoluene (40 mol %). The resulting mixture was stirred overnight at room temperature. After 
such time, saturated solution of NaHCO3 (6 mL) was added to the reaction mixture followed by 
the addition of water (6 mL). The organic layer was extracted by using ethyl acetate (10 mL x 3), 
dried over MgSO4, filtered and concentrated to afford the corresponding spirocycles.   
Synthesis of 2-phenyl-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.37 
 
Compound was synthesised according to the aforementioned general procedure D as brown oil 
(158 mg, 67%). 
FT-IR (cm-1): ν = 3160, 2991, 1668, 1650, 1630, 1251.  
1H NMR: (DMSO, 400 MHz) δ: 7.90 (d, J = 7.4 Hz, 2H), 7.60 (t, J = 7.5 Hz, 1H), 7.52 (t, J = 7.6 
Hz, 2H), 7.23 (d, J = 9.9 Hz, 2H), 6.27 (d, J = 9.9 Hz, 2H), 4.13 (s, 2H).   
13C NMR: (DMSO, 75 MHz) δ: 185.0, 162.1, 147.7, 132.1, 129.2, 128.5, 128.4, 127.1, 79.5, 64.1. 
HRMS: m/z calc’d for C14H12NO2 [M+H]
+ 227.0946, found 227.0945.  
Synthesis of 2-(4-chlorophenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.38 
 
Compound was obtained as brown solid (33 mg, 65 %) using the general procedure D. 




1H NMR: [CDCl3, 400 MHz)] δ: 7.88 (d, J = 8.8 Hz, 2H), 7.41 (d, J = 8.8 Hz, 2H), 6.92 (d, J = 10.0 
Hz, 2H), 6.30 (d, J = 10.0 Hz, 2H), 4.12 (s, 2H).  
13C NMR: [(CD3)2CO, 75 MHz) δ: 184.3, 164.3, 155.6, 136.6, 130.0, 129.1, 129.0, 128.9, 79.5, 64.4. 
HRMS: m/z calc’d for C14H10ClNO2 [M+H]
+ 260.0473, found 260.0477.  
Synthesis of 2-(4-methoxyphenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.39 
 
Compound was synthesised using general procedure D as colourless oil (28 mg, 56 %). 
FT-IR (cm-1): ν = 3080, 2925, 1666, 1648, 1632, 1608, 1253.  
1H NMR: (CDCl3, 400 MHz) δ: 7.87 (d, J = 8.8 Hz, 2H), 6.95-6.91 (m, 4H), 6.27 (d, J = 9.9 Hz, 
2H), 4.08 (s, 2H), 3.84 (s, 3H). 
13C NMR: (CDCl3, 75 MHz) δ: 184.8, 163.3, 162.6, 146.3, 130.2, 128.8, 119.1, 114.0, 79.1, 64.5, 
55.5.  
HRMS: m/z calc’d for C15H13NO3 [M]
+ 256.0968, found 256.0970.  
Synthesis of 2-(p-tolyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.40 
 
Compound was synthesised using general procedure D as light brown oil (13 mg, 26 %).s 
FT-IR (cm-1): ν = 3110, 2935, 1664, 1646, 1532, 1083, 973. 
1H NMR: (CDCl3, 400 MHz) δ: 7.86 (d, J = 8.1 Hz, 2H), 7.27 (d, J = 9.7 Hz, 2H), 6.97 (d, J = 9.9 




13C NMR: (CDCl3, 75 MHz) δ: 184.7, 163.5, 146.2, 142.6, 129.3, 128.8, 128.4, 124.0, 79.1, 64.6, 
21.6.  
HRMS: m/z calc’d for C15H14O2 [M+H]
+ 240.1019, found 240.1022.  
Synthesis of 2-mesityl-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.41 
 
Compound was obtained through general procedure D as pale yellow oil (36 mg, 36 %). 
FT-IR (cm-1): ν = 3040, 2921, 2830, 1716, 1671, 1635, 1611, 1574, 1429, 1248. 
1H NMR: (CDCl3, 400 MHz) δ: 6.94 (d, J = 10.0 Hz, 2H), 6.86 (s, 2H), 6.25 (d, J = 10.0 Hz, 2H), 
4.12 (s, 2H), 2.34 (s, 6H), 2.25 (s, 3H). 
13C NMR: (CDCl3, 75 MHz) δ: 184.7, 163.9, 146.1, 140.1, 137.0, 128.7, 128.5, 124.6, 78.8, 64.6, 
21.2, 19.9. 
HRMS: m/z calc’d for C17H17NO2 [M+H]
+ 268.1332, found 268.1341.  
Synthesis of 2-(3-nitrophenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.42 
 
Compound was synthesised using general procedure D as pale yellow oil (30 mg, 60 %). 
FT-IR (cm-1): ν = 3059, 2976, 2871, 1695, 1645, 1635, 1579, 1449, 1347, 1265, 1212. 
1H NMR: (CDCl3, 400 MHz) δ: 8.79 (t, J = 1.93 Hz, 1H), 8.41-8.37 (m, 1H), 8.31-8.28 (m, 1H), 




13C NMR: (CDCl3, 75 MHz) δ: 184.4, 161.4, 145.2, 134.1, 129.8, 129.2, 128.5, 126.4, 123.5, 79.9, 
64.7.  
HRMS: m/z calc’d for C14H10N2O4 [M+H]
+ 271.0713, found 271.0719. 
Synthesis of 2-(3,5-dimethylphenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.43 
 
Compound was synthesised using general procedure D as yellow oil (56 mg, 56 %). 
FT-IR (cm-1): ν = 3102, 1672, 1652, 1634, 1601, 1209. 
1H NMR: (CDCl3, 400 MHz) δ: 7.60 (s, 2H), 7.20 (s, 1H), 6.94 (d, J = 10.0 Hz, 2H), 6.29 (d, J = 
10.0 Hz, 2H), 4.14 (s, 2H), 2.40 (s, 6H).  
13C NMR: (CDCl3, 75 MHz) δ: 184.8, 163.9, 146.2, 138.4, 135.9, 134.0, 129.0, 126.3, 79.2, 64.6, 
21.3.    
HRMS: m/z calc’d for [M+H]+ C16H15NO2 254.1176, found 254.1180. 
Synthesis of 2-(2,3-dichlorophenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.44 
 
Compound was synthesised using general procedure D as colourless oil (30 mg, 30 %). 
FT-IR (cm-1): ν = 3060, 2991, 1667, 1634, 1414, 1195. 
1H NMR: (CDCl3, 400 MHz) δ: 7.69-7.67 (m, 1H), 7.63-7.60 (m, 1H), 7.31-7.27 (m, 1H), 7.00 (d, 




13C NMR: (CDCl3, 75 MHz) δ: 184.6, 161.7, 145.6, 134.7, 133.1, 132.1, 129.6, 129.1, 128.4, 127.3, 
79.6, 64.8.  
HRMS: m/z calc’d for C14H9Cl2NO2 [M+H]
+ 294.0083, found 294.0080.  
Synthesis of 2-(3,5-dinitrophenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.45 
 
Compound was synthesised using general procedure D as yellow oil (50 mg, 50 %). 
FT-IR (cm-1): ν = 3069, 1664, 1632, 1538, 1342, 1281, 1251.  
1H NMR: (CDCl3, 400 MHz) δ: 9.19-9.18 (m, 1H), 9.10-9.09 (m, 2H), 6.94 (d, J = 9.9 Hz, 2H), 
6.36 (d, J = 9.9 Hz, 2H), 4.24 (s, 2H).  
13C NMR: (CDCl3, 75 MHz) δ: 184.2, 159.7, 148.7, 144.6, 141.3, 129.5, 128.3, 121.4, 80.8, 65.0.  
HRMS: m/z calc’d for C14H9N3O6 [M+H]
+ 316.0564, found 316.0564. 
Synthesis of 2-(2,5-dibromophenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.46 
 
Compound was synthesised using general procedure D as light brown oil (32.5 mg, 65 %). 
FT-IR (cm-1): ν = 3063, 2920, 2841, 1718, 1670, 1634, 1576, 1455, 1238.  
1H NMR: (CDCl3, 400 MHz) δ: 7.90 (d, J = 2.5 Hz, 1H), 7.54 (d, J = 8.5 Hz, 1H), 7.45 (dd, J1 = 8.5 




13C NMR: (CDCl3, 75 MHz) δ: 184.6, 161.5, 145.4, 135.6, 135.3, 134.8, 129.8, 129.1, 121.2, 120.8, 
79.9, 64.8.   
HRMS: m/z calc’d for C14H9Br2NO2 [M+H]
+ 381.9073, found 381.9070.  
Synthesis of 2-(2-fluorophenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.47 
 
Compound was synthesised using general procedure as D light brown oil (51 mg, 86 %). 
FT-IR (cm-1): ν = 3115, 2936, 2856, 1654, 1641, 1536, 1066, 978, 756, 695. 
1H NMR: (CDCl3, 400 MHz) δ: 7.90-7.84 (m, 1H), 7.54-7.46 (m, 1H), 7.23-7.14 (m, 2H), 6.95 (d, 
J = 10.1 Hz, 2H), 6.30 (d, J = 10.1 Hz, 2H), 4.17 (s, 2H).  
13C NMR: (CDCl3, 75 MHz) δ: 184.6, 161.5 (d, J = 259 Hz), 145.8, 133.6 (d, J = 8.9 Hz), 131.1, 
129.0, 124.2 (d, J = 3.7 Hz), 116.9 (d, J = 21.7 Hz), 115.0 (d, J = 10.1 Hz), 78.7, 65.0.    
HRMS: m/z calc’d for C14H10FNO2 [M+H]
+ 244.0768, found 244.0770.    
Synthesis of 2-(3-(trifluoromethyl)phenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.48 
 
Compound was synthesised using general procedure D as yellow oil (50 mg, 63 %). 
FT-IR (cm-1): ν = 3046, 2936, 2836, 1714, 1670, 1635, 1626, 1571, 1409, 1320, 1250. 
1H NMR: (CDCl3, 300 MHz) δ: 8.22 (s, 1H), 8.14 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.58 




13C NMR: (CDCl3, 75 MHz) δ: 184.6, 162.2, 145.6, 131.6, 131.2 (q, J = 33 Hz), 129.2, 129.0, 128.6 
(q, J = 3.8 Hz), 127.5, 125.4 (q, J = 3.7 Hz), 123.8 (q, J = 273.3 Hz), 79.7, 64.7.  
HRMS: m/z calc’d for C15H10F3NO2 [M+H]
+ 294.0736, found 294.0741. 
Synthesis of 2-(4-(trifluoromethyl)phenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.49 
 
Compound was synthesised using general procedure D as pale yellow oil (70 mg, 70 %). 
FT-IR (cm-1): ν = 3048, 2934, 2850, 1715, 1673, 1635, 1620, 1575, 1412, 1320, 1249.  
1H NMR: (CDCl3, 400 MHz) δ: 8.08 (d, J = 8.2 Hz, 2H), 7.71 (d, J = 8.2 Hz, 2H), 6.96 (d, J = 10.0 
Hz, 2H), 6.32 (d, J = 10.0 Hz, 2H), 4.20 (s, 2H).  
13C NMR: (CDCl3, 75 MHz) δ: 184.7, 162.2, 145.7, 133.6 (q, J = 32.7 Hz), 130.1, 129.0, 128.8, 
125.5 (q, J = 3.69 Hz), 123.8 (q, J = 272.5 Hz), 79.7, 64.7.  
HRMS: m/z calc’d for C15H10F3NO2 [M+H]
+ 294.0736, found 294.0741.  
Synthesis of 2-(3,5-bis(trifluoromethyl)phenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.50 
 
Compound was synthesised using general procedure D as blood red oil (61 mg, 61 %). 
FT-IR (cm-1): ν = 3078, 2980, 1674, 1636, 1602, 1396, 1280, 1250. 
1H NMR: (CDCl3, 300 MHz) δ: 8.42 (s, 2H), 8.03 (s, 1H), 6.95 (d, J = 10.0 Hz, 2H), 6.34 (d, J = 




13C NMR: (CDCl3, 75 MHz) δ: 184.3, 161.0, 145.1, 132.3 (q, J = 34.4 Hz), 129.3, 128.9, 128.6 (q, 
J = 3.8 Hz), 125.3 (q, J = 3.7 Hz), 123.0 (q, J = 272.8 Hz), 80.1, 64.7. 
HRMS: m/z calc’d for C16H9F6NO2 [M+H]
+ 361.0537, found 361.0540.   
Synthesis of 2-(3-fluoro-4-methylphenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.51 
 
Compound was synthesised using general procedure D as light brown oil (75 mg, 94 %). 
FT-IR (cm-1): ν = 3056, 2961, 1678, 1632, 1602, 1389, 1283, 1252.  
1H NMR: (CDCl3, 300 MHz) δ: 7.64-7.56 (m, 2H), 7.28-7.22 (m, 1H), 6.93 (d, J = 10.1 Hz, 2H), 
6.30 (d, J = 10.1 Hz, 2H), 4.11 (s, 2H), 2.33 (d, J = 1.6 Hz, 3H).   
13C NMR: (CDCl3, 75 MHz) δ: 184.7, 161.0 (d, J = 245 Hz), 146.0, 131.6 (d, J = 5.3 Hz), 129.5 (d, 
J = 17.5 Hz), 128.9, 126.1 (d, J = 9.0 Hz), 124.0 (d, J = 3.8 Hz), 115.0 (d, J = 25 Hz), 79.4, 64.6.  
HRMS: m/z calc’d for C15H13FNO2 [M+H]
+ 258.0925, found 258.0929.  
Synthesis of 2-(furan-2-yl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.52 
 
Compound was synthesised using general procedure D as colourless oil (31 mg, 62 %). 
FT-IR (cm-1): ν = 3128, 2872, 2779, 1715, 1672, 1635, 1560, 1479, 1399, 1266.  
1H NMR: (CDCl3, 300 MHz) δ: 7.65-7.92 (m, 1H), 7.84-7.82 (m, 1H), 7.50 (t, J = 3.7 Hz, 1H), 6.99 
(d, J = 10.1 Hz, 2H), 6.32 (d, J = 10.1 Hz, 2H), 4.20 (s, 2H).  




HRMS: m/z calc’d for C12H9NO3 [M+H]
+ 216.0655, found 216.0655. 
Synthesis of 2-(1H-pyrrol-2-yl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.53 
 
Compound was synthesised using general procedure D as reddish oil (43 mg, 43 %). 
FT-IR (cm-1): ν = 3100, 2942, 2830, 1671, 1635, 1620, 1448, 1270.  
1H NMR: (CDCl3, 400 MHz) δ: 10.70 (s, 1H), 6.95-6.90 (m, 3H), 6.81-6.79 (m, 1H), 6.29-6.25 (m, 
3H), 4.10 (s, 2H).   
13C NMR: (CDCl3, 75 MHz) δ: 184.8, 158.6, 145.9, 129.1, 123.3, 118.8, 114.4, 110.3, 79.2, 63.7. 
HRMS: m/z calc’d for C12H11N2O2 [M+H]
+ 215.0815, found 215.0821.    
Synthesis of 2-(thiophen-2-yl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.55 
 
Compound was synthesised using general procedure D as pale yellow oil (35 mg, 70 %). 
FT-IR (cm-1): ν = 3090, 2861, 2760, 1667, 1648, 1633, 1428, 1250. 
1H NMR: (CDCl3, 400 MHz) δ: 7.62 (dd, J1 = 3.7 Hz, J2 = 1.1 Hz, 1H), 7.53 (dd, J1 = 3.7 Hz, J2 = 
1.1 Hz, 1H), 7.13 (dd, J1 = 5.0 Hz, J2 = 3.7 Hz, 1H), 6.95 (d, J = 10.1 Hz, 2H), 6.30 (d, J = 10.1 
Hz, 2H), 4.11 (s, 2H). 
13C NMR: (CDCl3, 75 MHz) δ: 184.7, 159.2, 146.0, 131.7, 131.0, 129.0, 128.9, 127.9, 79.9, 64.6.  
HRMS: m/z calc’d for C12H9NO2S [M+H]





Synthesis of 2-(3-chlorobenzo[b]thiophen-2-yl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.56 
 
Compound was synthesised using general procedure D as pale yellow oil (15 mg, 30 %). 
FT-IR (cm-1): ν = 3148, 3051, 2838, 2741, 1671, 1643, 1633, 1517, 1228. 
1H NMR: (CDCl3, 400 MHz) δ: 7.96-7.94 (m, 1H), 7.84-7.82 (m, 1H), 7.53-7.50 (m, 2H), 6.99 (dt, 
J1 = 10.1 Hz, J2 = 3.1 Hz, 2H), 6.32 (dt, J1 = 10.1 Hz, J2 = 3.1 Hz, 2H), 4.20 (s, 2H).   
13C NMR: (CDCl3, 75 MHz) δ: 184.7, 158.5, 145.5, 138.1, 137.0, 129.2, 127.8, 125.6, 125.2, 123.5, 
122.7, 122.1, 79.9, 64.6.  
HRMS: m/z calc’d for C16H10ClNO2S [M+H]
+ 316.0194, found 316.0195. 
Synthesis of 2-(pyridin-2-yl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.57 
 
Compound was synthesised using general procedure D as pale yellow oil (28 mg, 56 %). 
FT-IR (cm-1): ν = 3054, 2851, 2760, 1671, 1633, 1522, 1483, 1345, 1265.  
1H NMR: (CDCl3, 300 MHz) δ: 8.76-8.74 (m, 1H), 8.07-8.04 (m, 1H), 7.83 (td, J1 = 7.8 Hz, J2 = 
1.8 Hz, 1H), 7.48-7.43 (m, 1H), 6.98 (d, J = 10.2 Hz, 2H), 6.30 (d, J = 10.2 Hz, 2H), 4.20 (s, 2H). 
13C NMR: (CDCl3, 75 MHz) δ: 184.6, 150.1, 145.7, 136.9, 129.0, 126.2, 124.2, 80.0, 64.7.  
HRMS: m/z calc’d for C13H10N2O2 [M+H]






Synthesis of 2-(tert-butyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one 3.60 
 
Compound was synthesised using general procedure D as colourless oil (196 mg, 41 %). 
FT-IR (cm-1): ν = 2972, 2872, m1663, 1633, 1609, 1480, 1395, 1267, 1129. 
1H NMR: (CDCl3, 400 MHz) δ: 6.82 (d, J = 10.1 Hz, 2H), 6.24 (d, J = 10.1 Hz, 2H), 3.87 (s, 2H), 
1.26 (s, 9H).   
13C NMR: (CDCl3, 75 MHz) δ: 184.4, 161.4, 145.2, 134.1, 129.8, 128.5, 126.4, 123.5, 79.9, 64.7.  
HRMS: m/z calc’d for C12H15NO2 [M+H]
+ 205.1103, found 205.1110.   
Synthesis of N-(4-hydroxybenzyl)formamide 3.67 
 
Compound was prepared by general method A as white powder (Yield 2 g, 45%). 
FT-IR (cm-1): ν = 3248, 3076, 3000, 2929, 2853, 1632, 1574, 1546, 1462, 1427, 1354, 1282, 1182, 
1063, 1094, 974, 937, 872, 814, 756, 698, 654. 
1H NMR: (DMSO-d6, 400 MHz) δ: 9.06 (t, J = 6.3 Hz, 1H), 7.90-7.88 (m, 2H), 7.65 (t, J = 8.0 Hz, 
1H), 7.56-7.46 (m, 3H), 7.38 (d, J = 2.2 Hz, 1H), 7.10 (d, J = 8.0 Hz, 1H), 4.41 (d, J = 6.3 Hz, 
2H), 3.82 (s, 3H).   
13C NMR: (DMSO-d6, 75 MHz) δ: 166.6, 153.8, 134.7, 133.4, 131.7, 129.3, 128.8, 127.8, 129.7, 
121.1, 113.1, 56.5, 42.1.  
HRMS: m/z calc’d for C15H15ClNO2 [M+H]




Melting Point: Literature:133 117−118 °C, Experimental: 119-120 °C. 
Synthesis of 4-chloro-N-(2-hydroxymethyl)benzamide 3.71 
 
Compound was prepared by general method A as yellow solid (Yield 0.22 g, 35%). 
FT-IR (cm-1): ν = 3351, 3184, 2934, 1635, 1565, 1440. 
1H NMR: (DMSO-d6, 400 MHz) δ: 9.60 (s, 1H), 9.02 (t, J = 5.5 Hz, 1H), 7.94 (d, J = 8.4 Hz, 2H), 
7.60 (d, J = 8.4 Hz, 2H), 7.10-7.08 (m, 2H), 6.80-6.78 (m, 2H), 4.43 (d, J = 5.7 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 166.0, 155.3, 136.6, 133.5, 129.7, 128.9, 128.6, 128.3, 125.6, 
119.3, 115.5, 38.6. 
HRMS: m/z calc’d for C14H13ClNO2 [M+H]
+ 262.0629, found 262.0628.  
Melting Point: 190-194 °C. 
Synthesis of 2'-phenyl-2H,4'H-spiro[naphthalene-1,5'-oxazol]-2-one 3.77 
 
The compound was prepared by general procedure D to give the pure product as a pale yellow oil. 
(26 mg, 52%). 
FT-IR (cm-1): ν = 3160, 3053, 2869, 1715, 1673, 1652, 1603, 1569, 1547, 1367, 1338, 1283, 770. 
1H NMR: (CDCl3, 400 MHz) δ: 8.08-8.06 (m, 2H), 7.56-7.35 (m, 8H), 6.21 (d, J = 10.0 Hz, 1H), 




13C NMR: (CDCl3 75 MHz) δ: 197.7, 164.2, 145.8, 142.3, 131.8, 130.9, 129.6, 129.0, 128.9, 128.7, 
128.5, 126.9, 125.5, 123.6, 86.5, 69.7. 
HRMS: m/z calc’d for C18H13NO2 [M+H]
+ 276.1019, found 276.1019. 
HPLC: Chiralpak IB, 254 nm, hexane/IPA gradient (100:0 to 90:10 over 35 min), 1 mL/min, 
retention time (12.948, 15.064). 
Synthesis of 6-bromo-2'-phenyl-2H,4'H-spiro[naphthalene-1,5'-oxazol]-2-one 3.78 
 
This compound was obtained using the general procedure D. (Yield, 25.5 mg, 51%).  
FT-IR (cm-1): ν = 3273, 3060, 2922, 2869, 1718, 1679, 1655, 1602, 1579, 1556, 1483, 1367, 1338, 
1283, 1246.  
1H NMR: (CDCl3, 300 MHz) δ: 8.08-8.05 (m, 2H), 7.57-7.42 (m, 6H), 7.34-7.31 (m, 1H), 6.28 (d, 
J = 10.0 Hz, 1H), 4.51 (d, J = 15.0 Hz, 1H), 4.02 (d, J = 15.0 Hz, 1H), 
13C NMR: (CDCl3, 75 MHz) δ: 196.8, 164.2, 144.0, 140.9, 133.6, 132.1, 131.89, 130.9, 128.7, 128.5, 
127.3, 126.7, 124.8, 122.8, 86.1, 69.6.  
HRMS: m/z calc’d for C18H12BrNO2 [M+H]
+ 354.0124, found 356.0111+ 
HPLC: Chiralpak IB, 254 nm, hexane/IPA gradient (100:0 to 80:20 over 35 min), 1 mL/min, 
retention time (21.175, 23.621). 
Functionalisation of Spirocycles 
General Procedure E 
To the solution of the corresponding spirocycle (1 equiv.) in dry THF (5 mL) under argon 
atmosphere was added MeLi (1.2 equiv., 1.6 M in hexane) dropwise at ˗78 °C over 5 minutes. The 
reaction mixture was stirred at the same temperature for 1 hour. The reaction was monitored with 
TLC. The reaction was quenched with saturated NH4Cl solution (5 mL) at ˗78 




was extracted with ethyl acetate (2 x 5 mL), combined organic layers were washed with brine, 
dried over MgSO4, filtered and concentrated. The residue was purified by flash column 
chromatography using Pet. ether: Ethyl acetate (4:1 then 2:1) to yield the corresponding product. 
Experimental data for the major diastereomer is provided only.  
Synthesis of 2-mesityl-8-methyl-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-ol 3.81 
 
The compound was obtained as colourless oil using the general procedure E. (70 mg, 77%) 
Spectral data for major stereoisomer is given below. 
FT-IR (cm-1): ν = 3268, 2969, 2720, 1602, 1542, 1506, 1458, 1378, 1268.  
1H NMR: (CDCl3, 400 MHz) δ: 7.05 (s, 1H), 6.98 (d, J = 8.5 Hz, 1H), 6.80 (s, 2H), 6.68 (d, J = 8.5 
Hz, 1H), 6.30 (s, 1H), 5.90 (t, J = 5.5 Hz, 1H), 4.50 (d, J = 5.5 Hz, 2H), 2.30 (s, 9H), 2.20 (s, 3H).    
13C NMR: (CDCl3, 75 MHz) δ: 170.8, 154.0, 138.6, 134.6, 134.2, 130.9, 129.3, 128.3, 126.8, 124.5, 
115.2, 43.6, 21.1, 19.2, 15.9.  
HRMS: m/z calc’d for C18H21NO2 [M+H]
+ 284.1645, found 284.1645. 
Synthesis of 2-methyl-2'-phenyl-2H,4'H-spiro[naphthalene-1,5'-oxazol]-2-ol 3.82 
 
The compound was obtained as colourless oil using the general procedure E. (60 mg, 67%) 
Spectral data for major stereoisomer is given below. 




1H NMR: (CDCl3, 400 MHz) δ: (Major diastereomer) 7.97-7.95 (m, 2H), 7.48-7.45 (m, 1H), 7.39-
7.34 (m, 3H), 7.29-7.25 (m, 1H), 7.23-7.19 (m, 1H), 7.16-7.14 (m, 1H), 6.51 (d, J = 9.8 Hz, 1H), 
6.00 (d, J = 9.8 Hz, 1H), 4.44 (d, J = 15.4 Hz, 1H), 4.10 (d, J = 15.4 Hz, 1H), 2.67 (s, 1H), 1.32 
(s, 3H).  
13C NMR: (CDCl3, 75 MHz) δ: 163.2, 137.0, 134.5, 131.6, 131.4, 128.9, 128.6, 128.4, 128.3, 127.4, 
127.3, 124.9, 91.0, 72.7, 60.5, 21.3.  
HRMS: m/z calc’d for C19H17NO2 [M+H]
+ 292.1332, found 292.1336. 
Synthesis of Tyramine Based Amides 
Synthesis of N-(4-hydroxyphenethyl)Benzamide 3.84a 
 
Compound was prepared by general method B as off white solid (Yield 2 g, 63%). 
FT-IR (cm-1): ν = 3323, 3025, 1636, 1538, 1511, 1250.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.15 (s, 1H), 8.50 (t, J = 5.7 Hz, 1H), 7.80 (d, J = 7.3 Hz, 2H), 
7.50 (t, J = 7.2 Hz, 1H), 7.43 (t, J = 7.3 Hz, 2H), 7.01 (d, J = 8.3 Hz, 2H), 6.67 (d, J = 8.3 Hz, 2H), 
3.40 (q, J1 = 14.1 Hz, J2 = 6.6 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 166.6, 156.1, 135.2, 131.5, 130.0, 129.9, 128.7, 127.6, 115.5, 
41.8, 34.8.  
HRMS: m/z calc’d for C15H15NO2 [M+H]
+ 242.1176, found 242.1180.  








Synthesis of 4-chloro-N-(4-hydroxyphenethyl)benzamide 3.84b 
 
Compound was prepared by general method B as white solid (Yield 2.4 g, 68%). 
FT-IR (cm-1): ν = 3307, 2871, 2797, 1650, 1592, 1511, 1240.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.20 (s, 1H), 8.62 (t, J = 5.5 Hz, 1H), 7.84 (d, J = 8.6 Hz, 2H), 
7.53 (d, J = 8.6 Hz, 2H), 7.01 (d, J = 8.4 Hz, 2H), 6.68 (d, J = 8.4 Hz, 2H), 3.40 (q, J1 = 14.1 Hz, 
J2 = 6.6 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2H). 
13C NMR: (DMSO-d6, 75 MHz) δ: 165.5, 156.2, 136.4, 133.9, 130.0, 129.9, 129.5, 128.8, 115.6, 
41.8, 34.8. 
HRMS: m/z calc’d for C15H14ClNO2 [M+H]
+ 276.0786, found 276.0790.  
Melting Point: 178-179 ℃. 
Synthesis of N-(4-hydroxyphenethyl)-4-methoxybenzamide 3.84c 
 
Compound was prepared by general method B as white fluffy solid (Yield 1.6 g, 54%). 
FT-IR (cm-1): ν = 3315, 2890, 1645, 1427.  
1H NMR: (DMSO-d6, 400 MHz) δ: 9.20 (s, 1H), 8.40 (t, J = 5.5 Hz, 1H), 7.80 (d, J = 8.9 Hz, 2H), 
7.00 (m, 4H), 6.68 (d, J = 8.4 Hz, 2H), 3.80 (s, 3H), 3.39 (q, J1 = 14.0 Hz, J2 = 6.5 Hz, 2H), 2.70 
(t, J = 7.5 Hz, 2H).  
13C NMR: (DMSO-d6, 75 MHz) δ: 166.1, 162.0, 156.1, 130.1, 129.9, 129.4, 127.4, 115.6, 114.0, 




HRMS: m/z calc’d for C16H17NO3 [M+H]
+ 272.1281, found 272.1286.  
Melting Point: 170-171 ℃. 
Spirocyclisation of Tyramine Based Amides 
Synthesis of 2-phenyl-1-oxa-3-azaspiro[5.5]undeca-2,7,10-trien-9-one 3.85a 
 
Compound was synthesised using general procedure D as pale yellow oil (51 mg, 51 %). 
FT-IR (cm-1): ν = 3067, 2925, 2867, 2761, 1672, 1655, 1653, 1536, 1346, 1279, 1219.   
1H NMR: (CDCl3, 300 MHz) δ: 7.90 (d, J = 7.3 Hz, 2H), 7.45 (t, J = 7.3 Hz, 1H), 7.37 (t, J = 7.4 
Hz, 2H), 6.97 (d, J = 10.2 Hz, 2H), 6.30 (d, J = 10.2 Hz, 2H), 3.80 (t, J = 6.1 Hz, 2H), 2.00 (t, J = 
6.1 Hz, 2H).  
13C NMR: (CDCl3, 75 MHz) δ: 184.8, 154.4, 146.7, 133.2, 131.0, 129.0, 128.2, 127.1, 71.6, 40.2, 
30.4.  
HRMS: m/z calc’d for C15H13NO2 [M+H]
+ 240.1019, found 240.1019.  
Synthesis of 2-(4-chlorophenyl)-1-oxa-3-azaspiro[5.5]undeca-2,7,10-trien-9-one 3.85b 
 
Compound was synthesised using general procedure D as pale yellow oil (81 mg, 81 %). 




1H NMR: (CDCl3, 400 MHz) δ: 7.83 (dt, J1 = 8.6 Hz, J2 = 2.5 Hz, 2H), 7.33 (dt, J1 = 8.6 Hz, J2 = 
2.5 Hz, 2H), 6.94 (d, J = 10.2 Hz, 2H), 6.28 (d, J = 10.2 Hz, 2H), 3.73 (t, J = 6.2 Hz, 2H), 2.00 (t, 
J = 6.2 Hz, 2H). 
13C NMR: (CDCl3, 75 MHz) δ: 184.5, 153.3, 146.3, 137.0, 131.6, 129.1, 128.5, 128.4, 71.7, 40.2, 
30.3. 
HRMS: m/z calc’d for C15H12ClNO2 [M+H]
+ 274.0629, found 274.0629.  
Synthesis of 2-iodobenzene-1,3-diol 4.2 
 
The compound 4.2 was synthesised following literature procedure reported by Tsujiyama and co-
authors103. To a solution of resorcinol 4.1 (5.0 g, 45.41 mmol) in deionised water (45.45 mL) 
placed in an ice bath were added iodine (12.36 g, 48.72 mmol) and NaHCO3 (4.30 g, 51.28 mmol) 
in one portion. The resulting mixture was stirred at room temperature for half an hour. The obtained 
precipitates were filtered, extracted twice with diethyl ether (2 × 50 mL), dried over MgSO4, and 
concentrated to give 4.2 as a white solid (9.01 g, 84% yield).  
FT-IR (cm-1): ν = 3456, 3363, 1593, 1582, 1491, 1458, 1304, 1278, 1250, 1185, 1159, 1022, 994, 
784, 704.     
1H NMR: (CDCl3, 400 MHz) δ: 7.10 (t, J = 8.0 Hz, 1H), 6.55 (d, J = 8.0 Hz, 2H), 5.45 (s, 2H).  
13C NMR: (CDCl3, 75 MHz) δ: 155.9, 130.5, 107.5, 77.5.     
HRMS: m/z calc’d for C6H5IO2
+ [M+H]+ 235.9334, found 235.9333. 







Synthesis of diethyl 2,2'-((2-iodo-1,3-phenylene)bis(oxy))(2S,2'S)-dipropionate 4.4 
 
To a solution of 4.2 (0.50 g, 2.12 mmol) in THF (20 mL) under nitrogen at 0 °C were added 
triphenyl phosphine PPh3 (1.4g, 5.3 mmol) and ethyl-L-lactate (0.6 mL, 5.3 mmol). To this mixture 
diisopropyl azodicarboxylate (DIAD, 1.9 M in toluene, 1.04 mL, 5.3 mmol) was added dropwise 
and the resulting mixture was stirred for an hour in an ice bath and then at room temperature 
overnight. The reaction mixture was concentrated under vacuum and purified by flash column 
chromatography on silica gel (eluent: 9:1 petroleum ether 40-60/EtOAc) which afforded 4.4 as a 
colourless oil (1.25 g, 72% yield).90   
FT-IR (cm-1): ν = 2986, 1751, 1583, 1452, 1246.  
1H NMR: (CDCl3, 400 MHz) δ: 7.10 (t, J = 8.3 Hz, 1H), 6.31 (d, J = 8.3 Hz, 2H), 4.70 (q, J = 6.9 
Hz, 2H), 4.13–4.23 (m, 4H), 1.65 (d, J = 6.8 Hz, 6H), 1.20 (t, J = 7.3 Hz, 6H).  
13C NMR: (CDCl3, 75 MHz) δ: 171.9, 158.3, 129.6, 107.3, 81.0, 74.4, 61.6, 18.8, 14.5.   
HRMS: m/z calc’d for C16H22IO6
+ [M+H]+ 437.0456, found 437.0454. 
Synthesis of ((2R,2'R)-2,2'-((2-Iodo-1,3-phenylene)bis(oxy))dipropanoic acid 4.5 
 
To a solution of 4.4 (1.3g, 2.7 mmol) in THF (10 mL), methanol (10 mL) and 2 M NaOH (10 mL) 
were added and the reaction was left to stir at room temperature overnight. The reaction mixture 
was cooled to 0 °C, quenched with HCl (1M, 20 mL) and extracted with EtOAc (3 × 30 mL). The 
organic layers were dried over anhydrous MgSO4 and the solvents were removed in vacuum to 
give analytically pure 4.5 as a white solid (3.5 g, 99% yield).90 




1H NMR: (DMSO-d6, 400 MHz) δ: 7.24 (t, J = 8.1 Hz, 1H), 6.42 (d, J = 8.8 Hz, 2H), 4.88 (q, J = 
6.8 Hz, 2H), 1.58 (d, J = 6.7 Hz, 6H).   
13C NMR: (DMSO-d6, 100 MHz) δ: 173.6, 158.7, 130.7, 107.0, 81.0, 73.4, 19.4.  
HRMS: m/z calc’d for C16H22IO6 
+ [M+H]+ 380.9757, found 380.9755. 
Synthesis of (2S,2'S)-2,2'-((2-iodo-1,3-phenylene)bis(oxy))bis(N-mesitylpropanamide) 4.6 
 
To a solution of 4.5 (0.50 g, 2.12 mmol) in THF (20 mL) under nitrogen at 0 °C were added 
triphenyl phosphine PPh3 (1.4g, 5.3 mmol) and ethyl-L-lactate (0.6 mL, 5.3 mmol). To this mixture 
diisopropyl azodicarboxylate (DIAD, 1.9 M in toluene, 1.04 mL, 5.3 mmol) was added dropwise 
and the resulting mixture was stirred for an hour in an ice bath and then at room temperature 
overnight. The reaction mixture was concentrated under vacuum and purified by flash column 
chromatography on silica gel (eluent: 9:1 petroleum ether 40-60/EtOAc) which afforded 4.4 as a 
colourless oil (1.25 g, 72% yield).90   
FT-IR (cm-1): ν = 3251, 1670, 1532, 1469, 1256, 1131.  
1H NMR: (CDCl3, 400 MHz) δ: 8.03 (s, 2H), 7.36 (t, J = 8.3 Hz, 1H), 6.88 (s, 4H), 6.64 (d, J = 
8.3 Hz, 2H), 5.00 (q, J = 6.8 Hz, 2H), 2.26 (s, 6H), 2.15 (s, 12H), 1.77 (d, J = 6.7 Hz, 6H).   
13C NMR: (CDCl3, 75 MHz) δ: 170.0, 156.6, 137.3, 135.2, 130.6, 130.1, 128.9, 107.0, 80.4, 76.4, 
21.0, 18.8, 18.1.   








Synthesis of methyl 3,5-dihydroxy-4-iodobenzoate 4.8 
 
To a solution of 4.7 (1.80 g, 10.70 mmol) in MeOH (15 mL), a solution of NIS (2.20g, 9.77 mmol) 
in MeOH (15 mL) was added slowly at 0 oC. The reaction mixture was gradually brought to room 
temperature while stirring. After 16 h the reaction mixture was diluted with ice water and quenched 
by saturated Na2SO3, then extracted with ethyl acetate. The combined organic layers were washed 
with brine, dried over Na2SO4 and concentrated in vacuo. Recrystallisation with ethyl 
acetate/ethanol gave the desired compound as white solid in a yield of 2.54 g (8.64 mmol, 81%) 
with the same spectroscopic data as those previously reported.135 
1H NMR: (DMSO-d6, 400 MHz) δ: 10.53 (s, 2H), 6.95 (s, 2H), 3.80 (s, 3H) 
13C NMR: (DMSO-d6, 100 MHz) δ: 166.0, 158.2. 130.6, 104.8, 81.9, 52.2.   
HRMS: m/z calc’d for C8H8IO4
+ [M+H]+ 294.9462, found 294.9459. 
Synthesis of dimethyl 2,2'-((2-iodo-5-(methoxycarbonyl)-1,3-phenylene)bis(oxy))(2R,2'R)-bis(3-
phenylpropanoate) 4.10 
 
To a stirred suspension of methyl 3,5-dihydroxy-4-iodobenzoate 4.8 (0.5 g, 3.42 mmol), 
triphenylphosphine (PPh3) (2.44 g, 9.30 mmol) and benzyl-(S)-methyl-2-hydroxy-3-
phenylpropanoate 4.9 (1.29 g, 7.18 mmol) in tetrahydrofuran (32.0 mL) at 0 °C was added DIAD 
(1.55 mL, 7.90 mmol) dropwise over 30 minutes and the resulting mixture was warmed to room 




concentrated under reduced pressure. The residue was purified by flash column chromatography 
using petroleum ether/ ethyl acetate (9:1 and then 5:1) to give 4.10 as a white solid (1.38 g, 65%). 
Spectroscopic data is in accordance with the previously reported data.136       
FT-IR (cm-1): ν = 3028, 2952, 1753, 1721, 1577, 1434, 1417, 1325, 1243, 1197, 1113, 1011.  
1H NMR: (CDCl3, 400 MHz) δ: 7.44 (d, J = 7.5 Hz, 4H), 7.32 (t, J = 7.3 Hz, 4H), 7.28−7.25 (m, 
2H), 6.89 (s, 2H), 4.95 (dd, J1 = 7.6 Hz, J2 = 4.7, 2H), 3.85 (s, 3H), 3.70 (s, 6H), 3.34-3.31 (m, 
4H).  
13C NMR: (CDCl3, 100 MHz) δ: 170.5, 166.0, 158.0, 136.0, 131.6, 130.0, 128.5, 127.2, 106.4, 86.2, 
78.7, 52.5, 52.4, 39.0.    
HRMS: m/z calc’d for C28H28IO8
+ [M+H]+ 619.0823, found 619.0817. 
Synthesis of 1-iodo-2-isocyanatobenzene 4.12 
 
Triphosgene (1.08 g, 3.65 mmol) was added to a stirring solution of 2-iodoaniline 4.11 (2 g, 9.13 
mmol) in toluene (50 mL) at room temperature and the resulting solution was refluxed for 12 h. 
After cooling the reaction to room temperature, the reaction mixture was concentrated under 
vacuum (in a fume hood!). The residue was redissolved in 50 mL of hexane and filtered. The 
filtrate was concentrated to afford the desired isocyanates 4.12 as pale yellow oil in quantitative 
yield which was used in the next step without further purification.105 
1H NMR: (CDCl3, 400 MHz) δ: 7.82-7.80 (m, 1H), 7.34-7.30 (m, 1H), 7.16-7.14 (m, 1H), 6.95-6.90 
(m, 1H).  







Synthesis of 2-iodo-1,3-dinitrobenzene 4.14 
 
Sodium nitrite (0.83 g, 12 mmol) was added portion wise to sulfuric acid (9 mL) and the mixture 
was stirred and heated to 70 oC until the full dissolution of the solid. The resultant solution was 
cooled below 40 oC. 2,6-Dinitroaniline (2.0 g, 11 mmol) dissolved in AcOH (22 mL) was added 
dropwise to NaNO2 solution while the temperature was maintained below 40 
oC. The obtained 
solution was stirred for 30 minutes at room temperature. The reaction mixture was then poured in 
to a stirred solution of KI (2.0 g, 12 mmol) in water (20 mL) at 70 oC. The resultant mixture was 
stirred for 15 minutes then poured into 200 mL of H2O. The solid material was filtered, washed 
with water, and dried to give pale yellow solid (2.41g, 75%).   
FT-IR (cm-1): ν = 3087, 1530, 1366, 590.  
1H NMR: (CDCl3, 400 MHz) δ: 8.15 (d, J= 8.1 Hz, 2H), 7.84 (t, J= 8.1 Hz, 1H).  
13C NMR: (CDCl3, 100 MHz) δ: 156.5, 131.9, 127.3, 83.5. 
HRMS: m/z calc’d for C16H3IN2O4 [M
+] 293.9132, found 293.9136. 
Melting Point: Literature M.P. 137 = 113 oC, Experimental M.P. = 114-116 oC. 
Synthesis of 2-Iodoisophthalic acid 4.17 
 
To a solution of 2-Aminoisophthalic acid (2.0 g, 11.04 mmol) in conc. sulfuric acid (10 mL) at 0 
oC was added a solution of NaNO2 (1.15 g) in conc. H2SO4 (10 mL) at 0 
oC. The resulting solution 
was stirred gently and 85% phosphoric acid (20 mL) was added at a rate designed to maintain the 




time, urea (1.2 g) was added. The solution was stirred for 5 minutes and then poured in to ice and 
filtered. A solution of KI (3.6 g) in water (4 mL) was added to the filtrate and mixture was heated 
for 30 minutes. The mixture was cooled to 5 oC before filtration. The obtained solid was washed 
with sodium bisulfite solution (30 mL), and water (30 mL) and the dried. Recrystallisation from 
hot water afforded beige coloured solid (2.55 g, 80%). 
FT-IR (cm-1): ν = 2783, 2620, 2511, 1678, 1573, 597.  
1H NMR: (CDCl3, 400 MHz) δ: 13.36 (s, 2H), 7.59-7.57 (m, 2H), 7.53-7.49 (m, 1H).  
13C NMR: (CDCl3, 100MHz) δ: 169.7, 141.6, 130.1, 128.7, 91.5.  
HRMS: m/z calc’d for C8H5IO4 [M-H]
 ‒ 290.9158, found, 290.9161. 
Melting Point: Literature M.P. 138 = 236-238 oC, Experimental M.P. = 237-238 oC. 
Synthesis of 2-Iodo-1,3-diisocyanatobenzene 4.18 
 
A solution of 2-Iodoisophthalic acid (1.5 g, 5.14 mmol) in thionyl chloride (40 mL) was refluxed 
for 2h and evaporated under reduced pressure to afford crude 2-Iodoisophthaloyl chloride 
quantitatively. To a solution of the crude mixture in THF (15 mL) was added NaN3 (2.22 g in 8 
mL water) and stirred in an ice bath for 2h. To the mixed solution was added saturated NaHCO3 
(10 mL) solution and extracted with toluene (30 mL), dried over MgSO4 and evaporated to half 
under reduced pressure to give a toluene solution of 2-Iodoisophthaloyl diazide. Without 
purification, the crude mixture was refluxed for 2 hours in toluene to afford crude 2-Iodo-1,3-
diisocyanatobenzene as light brown liquid (1.42 g, 96%). The progress of the reaction was 
monitored by IR.115 
FT-IR (cm-1): ν = 3370, 3024, 2251, 2141, 1723, 1573, 1494, 1396, 1214, 781, 728.  
1H NMR: (CDCl3, 400 MHz) δ: 7.91 (d, J = 7.8 Hz, 2H), 7.66 (t, J= 7.8 Hz, 1H).  




HRMS: m/z calc’d for C8H3IN2O2 [M-CO+2H+H]
+ (259.9446), found 260.9516.  
The desired compound was observed as the [M-CO+2H+H]+ and [M-2CO+4H+H]+ adducts. This 
shows the degradation of the desired product to the amine and diamine.  
General Procedure F for the synthesis of C1 and C2-symmteric carbamates 4.20-4.22 and 4.23-4.25 
Crude Iodoisocyanatobenzene 4.12 or 4.18 (2.04 mmol) was added to a green heterogeneous 
mixture of corresponding L-lactate (2.04 mmol), reagent grade CuI (2.04 mmol) and dry DMF (25 
mL). The solution was stirred for 2.5 hours at room temperature then diluted with DEE (40 mL), 
washed with water (40 mL) and brine (50 mL), dried over MgSO4 and concentrated. The crude 
product was purified by flash column chromatography using Pet-EtOAc (5:1 and then 4:1) to 
afford pure desired product. 
Synthesis of ethyl (S)-2-(((2-iodophenyl)carbamoyl)oxy)propanoate 4.20 
 
Compound 4.20 was synthesised using general procedure F in 94% (0.7 g) yield as light brown 
oil. 
FT-IR (cm-1): ν = 3240, 2992, 2910, 2850, 2730, 2253, 1739, 1630, 1587, 1532, 1434, 1299, 902, 
715.  
1H NMR: (CDCl3, 400 MHz) δ: 7.95 (d, J = 8.2 Hz, 1H), 7.69-7.67 (m, 1H), 7.27-7.22 (m, 1H), 
7.04 (s, 1H), 6.75-6.71 (m, 1H), 5.06 (q, J = 7.1 Hz, 1H), 4.16 (q, J = 7.1 Hz, 2H), 1.48 (q, J = 7.1 
Hz, 2H), 1.22 (t, , J = 7.1 Hz, 3H).          
13C NMR: (CDCl3, 100 MHz) δ: 171.1, 152.5, 139.0, 138.0, 129.3, 125.4, 125.1, 89.2, 69.6, 61.5, 
17.1, 14.2.  
HRMS: m/z calc’d for C12H15INO4 [M+H]





Synthesis of (2S,5R)-2-isopropyl-5-methylcyclohexyl (2S)-2-(((2-
iodophenyl)carbamoyl)oxy)propanoate 4.21 
 
Compound 4.21 was synthesised using general procedure F in 71% (0.69 g) yield as pale yellow 
oil. 
FT-IR (cm-1): ν = 3310, 2950, 2890, 2253, 1738, 1690, 1575, 1524, 1434, 1213, 902, 720.  
1H NMR: (CDCl3, 400 MHz) δ: 8.05 (d, J = 7.9 Hz, 1H), 7.78 (dd, J1 = 7.9 Hz, J2 = 1.1 Hz, 1H), 
7.37-7.33 (m, 1H), 7.10 (s, 1H), 6.82 (td, J1 = 7.7 Hz, J2 = 1.4 Hz, 1H), 5.15 (q, J = 7.0 Hz, 1H), 
4.82-4.75 (m, 1H), 3.50 (q, J = 7.0 Hz, 1H), 2.02-1.92 (m, 2H), 1.74-1.69 (m, 3H), 1.57 (d, J = 7.1 
Hz, 3H), 1.42 (d, J = 7.0 Hz, 1H), 1.23 (t, J = 7.1 Hz, 1H), 0.93-0.90 (7H), 0.81 (d, J = 6.9 Hz, 
3H).  
13C NMR: (CDCl3, 100 MHz) δ: 170.6, 152.4, 138.9, 138.1, 129.3, 125.3, 88.8, 75.5, 69.7, 47.0, 
40.6, 34.2, 31.4, 26.3, 23.5, 22.0, 20.7, 17.1, 16.4.  
HRMS: m/z calc’d for C20H28INNaO4 [M+Na]
+ 496.0955, found 496.0934. 
Synthesis of tert-butyl (S)-2-(((2-iodophenyl)carbamoyl)oxy)propanoate 4.22 
 
Compound 4.22 was synthesised using general procedure F in 53% (0.42 g) yield as pale-yellow 
oil.  




1H NMR: (CDCl3, 400 MHz) δ: 7.93 (d, J = 8.2 Hz, 1H), 7.64 (dd, J1 = 8.0 Hz, J2 = 1.2 Hz, 1H), 
7.23-7.19 (m, 1H), 7.01 (s, 1H), 6.69 (td, J1 = 7.6 Hz, J2 = 1.3 Hz, 1H), 4.92 (q, J = 7.1 Hz, 1H), 
1.42 (d, J = 7.0 Hz, 3H), 1.39 (s, 9H).   
13C NMR: (CDCl3, 100 MHz) δ: 170.1, 152.5, 138.9, 138.2, 129.3, 125.3, 120.5, 89.0, 82.1, 70.0, 
28.0, 17.1,  
HRMS: m/z calc’d for C14H18INNaO4 [M+Na]
+ 414.0173, found 414.0173. 
Synthesis of diethyl 2,2'-((((2-iodo-1,3-phenylene)bis(azanediyl))bis(carbonyl))bis(oxy))(2S,2'S)-
dipropionate 4.23 
 
Compound 4.22 was synthesised using general procedure F in 98% (1.8 g) yield as pale yellow 
oil. 
FT-IR (cm-1): ν = 3310, 2950, 2890, 2253, 1738, 1690, 1575, 1524, 1434, 1213, 902, 720.   
1H NMR: (Acetone-d6, 400 MHz) δ: 8.01 (s, 2H), 7.57 (d, J = 7.9 Hz, 2H), 7.39 (t, J = 8.1 Hz, 1H), 
5.10 (q, J = 7.1 Hz, 2H), 4.24-4.16 (m, 4H), 1.51 (d, J = 7.1 Hz, 6H), 1.26 (t, J = 7.1 Hz, 6H).   
13C NMR: (MeOD, 100 MHz) δ: 171.5, 154.1, 140.0, 128.6, 122.0, 97.1, 69.6, 61.0, 16.0, 13.1. 
HRMS: m/z calc’d for C18H23IN2NaO8 [M+Na]
+ 545.0391, found 545.0388. 
Synthesis of bis((2S,5S)-5-isopropyl-2-methylcyclohexyl) 2,2'-((((2-iodo-1,3-
phenylene)bis(azanediyl))bis(carbonyl))bis(oxy))(2S,2'S)-dipropionate 4.24 
 




1H NMR: (Acetone-d6, 400 MHz) δ: 7.91 (s, 2H), 7.60 (d, J = 8.4 Hz, 2H), 7.38 (t, J = 8.1 Hz, 
1H), 5.08 (q, J = 7.0 Hz, 2H), 4.76 (td, J1 = 10.9 Hz, J2 = 4.3 Hz, 2H), 2.02-1.95 (m, 5H), 1.70 
(d, J = 11.7 Hz, 5H), 1.53-1.51 (m, 8H), 1.04 (t, J = 11.7 Hz, 2H), 0.93-0. 91 (m, 15H), 0.80 (d, J 
= 7.0 Hz, 7H).  
13C NMR: (Acetone-d6, 100 MHz) δ: 170.2, 153.0, 140.0, 129.0, 119.5, 91.4, 74.6, 69.6, 40.6, 34.1, 
31.2, 26.1, 23.5, 21.7, 20.3, 16.7, 16.1.  
HRMS: m/z calc’d for C34H51IN2O8Na [M+Na]
+ 765.2582, found 765.2573. 
   
Synthesis of di-tert-butyl 2,2'-((((2-iodo-1,3-
phenylene)bis(azanediyl))bis(carbonyl))bis(oxy))(2S,2'S)-dipropionate 4.25 
 
Compound 4.25 was synthesised using general procedure F in 35% (0.501 g) yield as colourless 
oil.  
1H NMR: (CDCl3, 400 MHz) δ: 7.67 (d, J = 8.2 Hz, 2H), 7.23 (t, J = 8.2 Hz, 1H), 6.99 (br, 2H), 
4.95 (q, J = 7.1 Hz, 2H), 1.44 (d, J = 7.1 Hz, 6H), 1.41 (s, 18H).   
13C NMR: (CDCl3, 100 MHz) δ: 170.1, 152.5, 138.6, 129.5, 116.7, 82.1, 69.9, 27.9, 17.1.  
HRMS: m/z calc’d for C22H35IN3O8 [M+NH4]
+ 596.1463, found 596.1461. 
 Synthesis of (S)-2-(1-hydroxy-3-phenylpropan-2-yl)isoindoline-1,3-dione 4.27a 
 
Compound 4.27a was prepared using known literature procedure139. A mixture of L-phenyl 




overnight under reflux. Distilled water (10 mL) was added to the reaction mixture and precipitates 
of the pure product were collected as off white solid. (1.5 g, 81%)  
FT-IR (cm-1): ν = 3462, 3089, 3062, 2938, 1772, 1705, 1611, 1497. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.78 (s, 4H), 7.20-7.16 (m, 2H), 7.11-7.09 (m, 3H), 5.03 (t, J = 
6.1 Hz, 1H), 4.49-4.41 (m 1H), 3.99-3.92 (m, 1H), 3.71-3.65 (m, 1H), 3.16-3.02 (m, 2H).   
13C NMR: (DMSO-d6, 100 MHz) δ: 168.6, 138.6, 134.8, 131.6, 129.1, 128.7, 126.8, 123.3, 61.1, 
55.9, 34.3.  
HRMS: m/z calc’d for C17H16NO3 [M+H]
+ 282.1125, found 282.1124. 
Melting Point: Literature M.P. 140 = 94-96 °C, Experimental M.P. = 93-95 °C. 
Synthesis of tert-butyl (S)-(1-hydroxy-3-phenylpropan-2-yl)carbamate 4.27b 
 
Compound 4.27b was prepared using known literature procedure119. Boc-anhydride (1.44 g, 6.61 
mmol) was added to a solution of L(-)-2-amino-3-phenyl-1-propanol (1 g, 6.61 mmol) and DIPEA 
(1.15 mL, 6.61 mmol) in THF (50 mL) under nitrogen at 0 oC. The mixture was then allowed to 
stir for 6h at room temperature. Solvent was removed under reduced pressure and the resulting 
residue was dissolved in 100 mL of EtOAc, washed twice with 100 mL of water then with 100 mL 
of brine, dried over MgSO4 and finally concentrated under reduced pressure to give desired 
compound as pale yellow solid. (Yield 1.59 g, 95%) 
FT-IR (cm-1): ν = 3373, 3277, 3075, 1660, 1541, 1367, 1283, 1174, 1058, 855, 830, 700. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.28-7.24 (m, 2H), 7.21-7.15 (m, 3H), 6.60 (d, J = 8.5 Hz, 1H), 
4.70 (t, J = 5.4 Hz, 1H), 3.59-3.54 (m, 1H), 3.30-3.24 (m, 2H), 2.84-2.79 (m, 1H), 2.59-2.53 (m, 




13C NMR: (DMSO-d6, 100 MHz) δ: 155.6, 139.9, 129.6, 128.5, 126.2, 77.8, 63.4, 54.4, 37.2, 27.3.   
HRMS: m/z calc’d for C14H22NO3 [M+H]
+ 252.1594, found 252.1596. 
Melting Point: Literature M.P.141 = 104-106 °C, Experimental M.P. = 96-98 °C. 
General procedure G for the synthesis of C2-symmetric iodoarenes 4.28a, b 
Compounds 4.28a, b were synthesised with the slight amendment to the known literature 
procedure.116 To a stirred solution of the protected amino alcohol 4.27a, b (0.40 g, 1.41 mmol) and 
triethyl amine (0.2 mL, 1.41 mmol) in anhydrous dichloromethane (6 mL) was added 2-Iodo-1,3-
diisocyanatobenzene 4.18 (0.2 g, 0.70 mmol) dropwise and the reaction mixture was allowed to 
stir overnight at room temperature. The reaction mixture was concentrated under reduced pressure 
and the residues were loaded on a short silica pad and were purified using petroleum ether/ ethyl 
acetate (5:1) to give the corresponding carbamate.  
Synthesis of bis((S)-2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropyl) (2-iodo-1,3-phenylene)dicarbamate 
4.28a 
 
The compound was obtained using general procedure G as yellow oil. (Yield 0.33 g, 56%). 
FT-IR (cm-1): ν = 3344, 3027, 2955, 1772, 1715, 1700, 1620, 1586, 1495, 1466, 1364, 1277, 1201, 
1087, 1013, 917, 785, 758, 698.   
1H NMR: (DMSO-d6, 400 MHz) δ: 7.71-7.56 (m, 8H), 7.42 (s, 1H), 7.19-7.10 (m, 11H), 6.93 (s, 
2H), 4.89-4.50 (m, 5H), 4.17-4.08 (m, 1H), 3.95-3.90 (m, 1H), 3.39-3.14 (m, 4H).   
13C NMR: (DMSO-d6, 100 MHz) δ: 168.3, 153.0, 147.8, 138.7, 136.8, 134.0, 131.4, 128.9, 128.6, 
126.9, 123.2, 90.4, 64.3, 52.0, 34.7.  
HRMS: m/z calc’d for C42H33IN4NaO8 [M+Na]




Synthesis of bis((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropyl) (2-iodo-1,3-
phenylene)dicarbamate 4.28b 
 
The compound was obtained using general procedure G as colourless oil. (Yield 0.58 g, 64%). 
FT-IR (cm-1): ν = 3338, 2978, 1702, 1687, 1589, 1531, 1492, 1468, 1453, 1391, 1292, 1265, 1167, 
1091, 1054, 854, 785, 753, 698.   
1H NMR: (DMSO-d6, 400 MHz) δ: 7.35-7.15 (m, 13H), 6.89 (d, J = 8.3 Hz, 2H), 6.60 (d, J = 8.3 
Hz, 1H), 4.04-3.87 (m, 5H), 3.61-3.53 (m, 1H), 3.30-3.25 (m, 1H), 2.84-2.64 (m, 4H), 1.33 (s, 
18H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 155.6, 154.5, 140.9, 138.8, 128.6, 128.5, 126.5, 126.2, 88.6, 
78.1, 66.0, 54.4, 37.4, 28.7. 
HRMS: m/z calc’d for C36H45IN4NaO8 [M+Na]
+ 811.2174, found 811.2138. 
General procedure E for the synthesis of C1 & C2-symmetric iodoarenes bearing urea arm 
To the solution of the corresponding isocyanate (0.7 mL, 4.34 mmol, 1 equiv.) in THF (60 mL) 
kept at 0 oC was added the solution of amine (0.73 g, 4.75 mmol, 1.1 equiv.) in THF (10 mL) 
dropwise. The ice bath was removed and the reaction mixture was brought to room temperature. 
The reaction mixture was stirred for 3-4 hours or until the TLC analysis showed the completion. 
The reaction mixture was concentrated under reduced pressure. The residue were washed hexane 
multiple times. Recrystallisation either with dichloromethane/ ethyl acetate or ethanol provided 







Synthesis of (S)-1-(1-hydroxy-3-phenylpropan-2-yl)-3-(2-iodophenyl)urea 4.29 
 
Compound 4.29 was prepared using general procedure E as pale yellow solid. (1.64 g, 95%)   
FT-IR (cm-1): ν = 3356, 3298, 3021, 2918, 2874, 2821, 1693, 1629, 1607, 1573, 1462, 1432, 1380, 
1088.  
1H NMR: (DMSO-d6, 400 MHz) δ: 7.79-7.76 (m, 2H), 7.64 (s, 1H), 7.31-7.24 (m, 5H), 7.22-7.19 
(m, 1H), 7.12 (d, J = 8.2 Hz, 1H), 6.74 (td, J1 = 7.6 Hz, J2 = 1.5 Hz, 1H), 4.91 (s, 1H), 3.89-3.79 
(m, 1H), 3.42-3.34 (m, 2H), 2.89-2.84 (m, 1H), 2.72-2.67 (m, 1H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 155.0, 141.1, 139.6, 139.2, 129.7, 128.8, 128.6, 126.4, 124.5, 
122.7, 90.4, 62.8, 53.3, 37.7.  
HRMS: m/z calc’d for C16H18IN2O2 [M+H]
+ 397.0407, found 397.0405. 
Melting Point: 156-157 °C. 
Synthesis of (S)-1-(2-iodophenyl)-3-(1-phenylethyl)urea 4.31 
 
Compound 4.31 was prepared using general procedure E as pale yellow solid. (0.71 g, 96%)   
FT-IR (cm-1): ν = 3278, 2974, 1731, 1636, 1576, 1525, 1494, 1463, 1433, 1276, 1016, 730, 695. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.85 (dd, J1 = 8.3 Hz, J2 = 1.4 Hz, 1H), 7.78 (dd, J1 = 7.9 Hz, J2 
= 1.4 Hz, 1H), 7.60-7.58 (m, 2H), 7.36-7.34 (m, 4H), 7.29-7.24 (m, 2H), 6.74 (td, J1 = 7.7 Hz, J2 




13C NMR: (DMSO-d6, 100 MHz) δ: 154.6, 145.5, 140.9, 139.3, 128.9, 128.8, 127.2, 126.3, 124.5, 
122.3, 90.3, 49.3, 23.6.  
HRMS: m/z calc’d for C15H16IN2O [M+H]
+ 367.0302, found 367.0300. 
Melting Point: 165-166 °C. 
Synthesis of 1,1'-(2-iodo-1,3-phenylene)bis(3-((S)-1-hydroxypropan-2-yl)urea) 4.38a  
Compound 4.31 was prepared using general procedure E as white solid. (0.501 g, 81%)  
 
FT-IR (cm-1): ν = 3284, 2980, 2851, 2359, 2341, 1632, 1162, 1035, 988, 741.   
1H NMR: (DMSO-d6, 400 MHz) δ: 7.60 (s, 2H), 7.40 (d, J = 7.9 Hz, 2H), 7.14 (t, J = 8.1 Hz, 1H), 
6.90 (d, J = 7.6 Hz, 2H), 4.78 (s, 2H), 3.70-3.65 (m, 2H), 3.42-3.28 (m, 4H), 1.08 (d, J = 6.8 Hz, 
6H). 
13C NMR: (DMSO-d6, 100 MHz) δ: 155.1, 141.6, 128.2, 117.5, 89.7, 65.2, 47.4, 18.2.  
HRMS: m/z calc’d for C14H22IN4O4 [M+H]
+ 437.0680, found 437.0698. 
Melting Point: 249-250 °C. 
Synthesis of 1,1'-(2-iodo-1,3-phenylene)bis(3-((S)-1-hydroxybutan-2-yl)urea) 4.38b 





FT-IR (cm-1): ν = 3290, 2962, 2930, 2873, 2355, 1633, 1556, 1463, 1410, 1274, 1223, 1074, 1018, 
784, 737, 639. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.62 (s, 2H), 7.39 (d, J = 8.1 Hz, 2H), 7.14 (t, J = 8.1 Hz, 1H), 
6.84 (d, J = 8.1 Hz, 2H), 4.78 (s, 2H), 3.56-3.42 (m, 4H), 3.35-3.32 (m, 2H), 1.64-1.54 (m, 2H), 
1.43-1.31 (m, 2H), 0.89 (t, J = 7.4 Hz, 6H).   
13C NMR: (DMSO-d6, 100 MHz) δ: 155.4, 141.7, 128.2, 117.5, 89.7, 63.4, 53.0, 24.7, 10.9.  
HRMS: m/z calc’d for C16H26IN4O4 [M+H]
+ 465.0993, found 465.0990. 
Melting Point: 252-254 °C. 
Synthesis of 1,1'-(2-iodo-1,3-phenylene)bis(3-((S)-1-hydroxy-3-phenylpropan-2-yl)urea) 4.38c 
Compound 4.31 was prepared using general procedure E as yellow solid. (1.74 g, 85%)  
 
FT-IR (cm-1): ν = 3297, 3024, 2919, 1634, 1548, 1465, 1271, 725, 695. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.65 (s, 2H), 7.32-7.20 (m, 12H), 7.10 (t, J = 8.1 Hz, 1H), 6.99 
(d, J = 8.1 Hz, 2H), 4.91 (s, 2H), 3.85-3.78 (m, 2H), 3.43-3.32 (m, 4H), 2.89-2.70 (m, 4H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 155.2, 141.6, 139.6, 129.7, 128.6, 126.4, 117.7, 90.0, 62.8, 53.3, 
37.7.   
HRMS: m/z calc’d for C26H30IN4O4 [M+H]
+ 589.1306, found 589.1321. 








Synthesis of 1,1'-(2-iodo-1,3-phenylene)bis(3-((1S,2R)-2-hydroxy-1,2-diphenylethyl)urea) 4.38d 
Compound 4.31 was prepared using general procedure E as white solid. (0.37 g, 74%)  
 
FT-IR (cm-1): ν = 3343, 3213, 2981, 1647, 1587, 1556, 1503, 1465, 1396, 1276, 1231, 1068, 1047, 
741. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.98 (s, 2H), 7.67 (d, J = 8.8 Hz, 2H), 7.47 (d, J = 7.4 Hz, 4H), 
7.42 (d, J = 7.4 Hz, 4H), 7.36-7.32 (m, 8H), 7.26-7.20 (m, 4H), 7.07-7.06 (m, 2H), 6.99-6.95 (m, 
1H), 5.68 (d, J = 4.1 Hz, 2H), 4.90-4.85 (m, 4H).   
13C NMR: (DMSO-d6, 100 MHz) δ: 155.1, 144.1, 143.2, 141.5, 128.2, 128.1, 127.9, 127.6, 127.3, 
127.0, 126.9, 118.1, 90.4, 76.0, 59.6.   
HRMS: m/z calc’d for C36H33IN4O4 [M+Na]
+ 735.1439, found 735.1441. 
Melting Point: 221-223°C. 
Synthesis of 1,1'-(2-iodo-1,3-phenylene)bis(3-((1R,2S)-1-hydroxy-2,3-dihydro-1H-inden-2-yl)urea) 
4.38e 
Compound 4.31 was prepared using general procedure E as off-white solid. (0.52 g, 63%)  
 




1H NMR: (DMSO-d6, 400 MHz) δ: 8.10 (s, 2H), 7.47 (d, J = 8.1 Hz, 2H), 7.29-7.20 (m, 11H), 5.23 
(d, J = 4.1 Hz, 2H), 5.12 (dd, J1 = 8.7 Hz, J2 = 4.9 Hz, 2H), 4.48 (q, J = 4.5 Hz, 2H), 3.08 (dd, J1 
= 16.2 Hz, J2 = 4.6 Hz, 2H), 2.82 (d, J = 16.1 Hz, 2H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 155.9, 143.6, 141.9, 141.0, 128.2, 127.6, 126.7, 125.4, 124.5, 
118.7, 91.3, 72.7, 58.1, 25.6.    
HRMS: m/z calc’d for C26H25IN4O4 [M+H]
+ 585.0993, found 585.0989. 
Melting Point: 247-248 °C 
Synthesis of (2S,2'S)-2,2'-((((2-iodo-1,3-phenylene)bis(azanediyl))bis(carbonyl))bis(azanediyl))bis(3-
phenylpropanoic acid) 4.38f 
Compound 4.38f was prepared using general procedure E as pale-yellow solid. (0.76 g, 70%)  
 
FT-IR (cm-1): ν = 3217, 3025, 2890, 1714, 1638, 1547, 1494, 1464, 1407, 1275, 1214, 1075, 745. 
1H NMR: (DMSO-d6, 400 MHz) δ: 7.88 (s, 2H), 7.33-7.21 (m, 16H), 7.15-7.11 (m, 1H), 4.48-4.41 
(m, 2H), 3.14-3.08 (m, 2H), 2.98-2.91 (m, 2H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 173.9, 170.7, 155.0, 141.4, 137.8, 129.9, 128.7, 127.0, 118.2, 
90.5, 54.5, 38.0.  
HRMS: m/z calc’d for C26H26IN4O6 [M+H]
+ 617.0892, found 617.0898. 








Synthesis of (S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropyl benzoate 4.39 
 
Compound 4.39 was synthesised by the known literature procedure120. To a solution of the 4.27b 
(1.0 g, 3.98 mmol), triethyl amine (0.78 mL, 5.57 mmol) in chloroform (20 mL) kept at 0 oC was 
added benzoyl chloride (0.60 mL, 5.17 mmol) dropwise. The reaction was allowed to stir for 5 
hours under continuous cooling. The reaction mixture was concentrated under reduced pressure 
and the residue were loaded on a short silica pad and were purified using petroleum ether: ethyl 
acetate (5:1) to afford 4.39 as colourless oil (yield: 1.21 g, 85%).      
FT-IR (cm-1): ν = 3365, 2978, 1712, 1695, 1601, 1520, 1453, 1389, 1365, 1284, 1246, 1158, 1059, 
734.  
1H NMR: (CDCl3, 400 MHz) δ: 8.07 (d, J = 7.4 Hz, 2H), 7.60 (t, J = 7.5 Hz, 1H), 7.50 (t, J = 7.7 
Hz, 2H), 7.34-7.31 (m, 2H), 7.27-7.24 (m, 3H), 4.75 (s, 1H), 4.33-4.25 (m, 3H), 2.99-2.90 (m, 
2H), 1.43 (s, 9H).  
13C NMR: (CDCl3, 100 MHz) δ: 166.4, 162.3, 135.4, 133.2, 130.6, 129.3, 129.0, 128.9, 128.7, 126.7, 
79.8, 65.7, 50.8, 38.1, 28.3.   
HRMS: m/z calc’d for C21H26NO4 [M+H]
+ 355.1784, found 355.1780. 











phenylpropane-2,1-diyl) dibenzoate 4.40 
 
The compound 4.39 (0.2 g, 0.56 mmol) was placed in 15 mL round bottom flask under nitrogen 
atmosphere at 0 oC. TFA (2 mL) was added slowly and the reaction mixture was stirred overnight 
at room temperature. The reaction mixture was concentrated under reduced pressure. The obtained 
residue 4.39a were used as such for the next step. The residue of the compound 4.39a were coupled 
with 4.18 according to the general procedure E to give 4.40 as yellow solid (0.12 g, 49%).        
FT-IR (cm-1): ν = 3288, 3064, 2923, 2852, 1716, 1641, 1538, 599.   
1H NMR: (DMSO-d6, 400 MHz) δ: 8.05-8.02 (m, 4H), 7.70-7.66 (m, 2H), 7.57-7.52 (m, 4H), 7.41-
7.37 (m, 2H), 7.33-7.30 (m, 10H), 7.26-7.21 (m, 4H), 7.14-7.08 (m, 1H), 4.36-4.17 (m, 6H), 2.99-
2.84 (m, 4H). 
13C NMR: (DMSO-d6, 100 MHz) δ: 166.1, 155.1, 149.8, 138.6, 133.9, 130.1, 129.9, 129.7, 129.2, 
128.8, 128.4, 126.7, 88.5, 66.6, 50.2, 37.8.  
HRMS: m/z calc’d for C40H38IN4O6 (M+H)
+ 797.1831, found  797.1835. 
Melting Point: 230-232 °C 
Synthesis of 1-((S)-1-hydroxy-3-phenylpropan-2-yl)-3-((S)-1-phenylpropyl)urea 4.45 
 
The compound 4.45 was synthesised according to the general procedure E as colourless oil (0.41 




FT-IR (cm-1): ν = 3336, 3026, 2927, 2356, 2341, 1610, 1586, 1565, 1493, 1449, 1380, 1253, 1073, 
1046, 740, 696.  
1H NMR: (DMSO-d6, 400 MHz) δ: 7.31-7.16 (m, 10H), 6.40 (d, J = 8.6 Hz, 1H), 5.80 (d, J = 8.6 
Hz, 1H), 4.84 (s, 1H), 4.51 (q, J = 7.3 Hz, 1H), 3.71-3.67 (m, 1H), 3.35-3.25 (m, 2H), 2.80-2.75 
(m, 1H), 2.62-2.57 (m, 1H), 1.67-1.53 (m, 2H), 0.79 (t, J = 7.3 Hz, 3H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 157.7, 145.1, 139.6, 129.7, 128.5, 128.4, 126.6, 63.0, 54.8, 52.9, 
37.7, 30.5, 11.1. 
HRMS: m/z calc’d for C19H25N2O2 (M+H)
+ 313.1911, found 313.1909. 
Melting Point: 130-131 °C 
General procedure I for the synthesis of C1 & C2-symmetric iodoarenes bearing urea and carbamate 
arm 
To the solution of the corresponding isocyanate (0.5 g, 2.04 mmol, 1 equiv.) in THF (30 mL) kept 
at 0 oC was added the solution of amine (0.48 g, 2.24 mmol, 1.1 equiv.) and triethylamine (0.57 
mL, 4.08 mmol, 2.0 equiv.) in THF (10 mL) dropwise. The ice bath was removed and the reaction 
mixture was brought to room temperature. The reaction mixture was stirred overnight. The reaction 
mixture was concentrated under reduced pressure. The residue was washed with hexane multiple 
times. Recrystallisation either with dichloromethane/ ethyl acetate or ethanol provided the desired 
compound.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Synthesis of benzyl ((2-iodophenyl)carbamoyl)-L-alaninate 4.34 
 
The compound 4.34 was synthesised according to the general procedure I as pale yellow solid 
(0.37 g, 88%).        
FT-IR (cm-1): ν = 3299, 3060, 2979, 2605, 2498, 1720, 1633, 1556, 1512, 1463, 1452, 1432, 1318, 




1H NMR: (DMSO-d6, 400 MHz) δ: 7.84-7.79 (m, 2H), 7.74 (s, 1H), 7.58 (d, J = 6.9 Hz, 1H), 7.39-
7.27 (m, 6H), 6.77 (t, J = 7.4 Hz, 1H), 5.20-5.12 (m, 2H), 4.33-4.26 (m, 1H), 1.36 (d, J = 7.4 Hz, 
3H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 173.7, 154.9, 140.7, 139.3, 136.5, 129.0, 128.9, 128.4, 128.1, 
124.9, 122.5, 90.5, 66.3, 48.9, 18.0.  
HRMS: m/z calc’d for C17H18IN2O3 (M+H)
+ 425.0357, found 425.0359. 
Melting Point: 161-163 °C 
Synthesis of methyl ((2-iodophenyl)carbamoyl)-L-leucinate 4.36 
 
The compound 4.36 was synthesised according to the general procedure I as yellow solid (0.58 g, 
73%).  
FT-IR (cm-1): ν = 3301, 2951, 2868, 1737, 1641, 1573, 1557, 1519, 1463, 1433, 1367, 1273, 1255, 
1205, 1155, 1016, 980, 762, 743, 653.   
1H NMR: (DMSO-d6, 400 MHz) δ: 7.84-7.78 (m, 2H), 7.72 (s, 1H), 7.51 (d, J = 7.5 Hz, 1H), 7.27 
(t, J = 8.1 Hz, 1H), 6.76 (t, J = 7.5 Hz, 1H), 4.26-4.21 (m, 1H), 3.65 (s, 3H), 1.73-1.66 (m, 1H), 
1.58 (t, J = 7.3 Hz, 2H), 0.93 (d, J = 6.5 Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 174.2, 155.1, 140.7, 139.4, 128.9, 124.8, 122.5, 90.5, 52.3, 51.5, 
41.0, 24.8, 23.2.  
HRMS: m/z calc’d for C14H20IN2O3 (M+H)
+ 391.0513, found 391.0510. 






Synthesis of bis((S)-3-phenyl-2-(3-((S)-1-phenylpropyl)ureido)propyl) (2-iodo-1,3-
phenylene)dicarbamate 4.46 
 
The compound 4.46 was synthesised according to the general procedure I as dark brown solid 
(0.73 g, 65%).  
FT-IR (cm-1): ν = 3270, 3026, 2961, 1702, 1633, 1584, 1519, 1461, 1398, 1202, 1109, 1109, 1018, 
745, 696, 621.   
1H NMR: (DMSO-d6, 400 MHz) δ: 9.02 (s, 2H), 7.32-7.19 (m, 23H), 6.45 (d, J = 8.0 Hz, 2H), 5.87 
(d, J = 8.0 Hz, 2H), 4.56-4.49 (m, 2H), 4.02-3.95 (m, 6H), 2.83-2.72 (m, 4H), 1.67-1.59 (m, 4H), 
0.79 (t, J = 7.0 Hz, 6H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 157.4, 154.6, 144.9, 141.0, 138.7, 129.7, 128.7, 128.6, 126.6, 
83.9, 66.2, 54.9, 50.2, 37.7, 30.4, 11.2. 
HRMS: m/z calc’d for C46H52IN6O6 (M+H)
+ 933.2807, found 933.2813. 
Melting Point: 249-251 °C 
Synthesis of (Z)-N'-hydroxybenzimidamide 4.42a 
 
Known literature procedure was used to synthesise this compound.142 To a solution of benzonitrile 
(5 mL, 48.48 mmol) in dry ethanol (50 mL) was added 50% aq. hydroxylamine (2.25 mL, 72.73 




pressure. Residues were purified by flash chromatography using petroleum ether and ethyl acetate 
Pet-EtOAc (1:1) as eluents to afford pure product as white crystals (3.66 g, 92%). 
FT-IR (cm-1): ν = 3590, 3525, 3419, 2920, 1644, 1594, 1576.        
1H NMR: (DMSO-d6, 400 MHz) δ: 9.65 (s, 1H), 7.71-7.67 (m, 2H), 7.38-7.36 (m, 3H), 5.82 (s, 2H). 
13C NMR: (DMSO-d6, 100 MHz) δ: 151.3, 129.9, 129.3, 128.5, 125.8. 
HRMS: m/z calc’d for C7H9N2O (M+H)
+ 137.0709, found 137.0707. 
Melting Point: Literature M.P.142 = 65-66 °C, Experimental M.P. = 65-67 °C.   
Synthesis of N-Phenylcyanamide 4.42b 
 
Known literature procedure was used to synthesise this compound.142 To a stirred solution of 
benzamidoxime (2.45 g, 17.99 mmol), in pyridine (18 mL) at 0 oC was added tosyl chloride (3.6 
g, 18.9 mmol) under nitrogen. The mixture was stirred at 0 oC for 10 minutes then at room 
temperature for 5 hours. The reaction mixture was concentrated under reduced pressure. Residues 
were purified by flash chromatography using petroleum ether and ethyl acetate Pet-EtOAc (5:1 
and then 4:1) as eluents to afford pure product as white powder (1.3 g, 61%).  
FT-IR (cm-1): ν = 3459, 3170, 2988, 2911, 2221, 1592. 
1H NMR: (DMSO-d6, 400 MHz) δ: 10.14 (s, 1H), 7.35-7.31 (m, 2H), 7.03-6.97 (m, 3H).  
13C NMR: (DMSO-d6, 100 MHz) δ: 139.0, 130.1, 122.9, 115.3, 112.4. 
HRMS: m/z calc’d for C7H7N2 (M+H)
+ 119.0604, found 119.0604. 







General procedure J for the synthesis of C2-symmetric iodoarenes bearing chiral amide appendage 
To the solution of the 2-iodoisophthaloyl dichloride (0.40 g, 1.22 mmol, 1 equiv.) in 
dichloromethane (40 mL) kept at 0 oC was added the solution of amine (0.49 g, 2.70 mmol, 2.2 
equiv.) and triethylamine (0.74 mL, 7.32 mmol, 6.0 equiv.) in THF (10 mL) dropwise. The ice 
bath was removed and the reaction mixture was brought to room temperature. The reaction mixture 
was stirred overnight. The reaction mixture was concentrated under reduced pressure. The residue 
was redissolved in ethyl acetate and washed with 2 M HCl (10 ml). The organic layers were 
separated, combined, dried over MgSO4 and concentrated under reduced pressure. 
Recrystallisation of the residue with dichloromethane/ ethyl acetate provided the desired 
compound.            
Synthesis of dimethyl 2,2'-((2-iodoisophthaloyl)bis(azanediyl))(2S,2'S)-bis(4-methylpentanoate) 
4.47a 
 
The compound 4.47a was synthesised according to the general procedure J as yellow solid (0.27 
g, 40%).  
FT-IR (cm-1): ν = 3271, 2955, 2605, 1739, 1650, 1528, 1434, 1267, 1200, 693. 
1H NMR: (CDCl3, 400 MHz) δ: 7.43-7.34 (s, 3H), 6.30 (d, J = 8.5 Hz, 2H), 4.85-4.79 (m, 2H), 3.77 
(m, 6H), 1.90-1.63 (m, 6H), 1.02-0.96 (m, 12H).   
13C NMR: (CDCl3, 100 MHz) δ: 173.0, 169.0, 143.9, 128.8, 128.6, 90.4, 52.5, 51.2, 41.4, 24.9, 22.9. 
HRMS: m/z calc’d for C22H32IN2O6 (M+Na)
+ 569.1119, found 569.1118. 







Synthesis of diethyl 2,2'-((2-iodoisophthaloyl)bis(azanediyl))(2S,2'S)-bis(3-phenylpropanoate) 4.47b 
 
The compound 4.47b was synthesised according to the general procedure J as yellow solid (0.38 
g, 65%).  
FT-IR (cm-1): ν = 3278, 2978, 1731, 1650, 1525, 1368, 1209, 1117, 1031, 695. 
1H NMR: (DMSO-d6, 400 MHz) δ: 8.94 (d, J = 7.8 Hz, 2H), 7.43 (t, J = 7.6 Hz, 1H), 7.34-7.29 (m, 
8H), 7.26-7.21 (m, 2H), 7.05 (d, J = 7.6 Hz, 2H), 4.65-4.60 (m, 2H), 4.16-4.08 (m, 4H), 3.16-2.97 
(m, 4H), 1.18 (t, J = 7.1 Hz, 6H).   
13C NMR: (DMSO-d6, 100 MHz) δ: 171.6, 169.3, 144.3, 137.8, 129.7, 128.7, 128.4, 127.0, 92.0, 
61.1, 54.3, 36.9, 14.6. 
HRMS: m/z calc’d for C30H32IN2O6 (M+H)
+ 643.1300, found 643.1306. 
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